- Sunday, October 1, 2023
8:00 AM – 8:07 AM PT
100 - Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women with Low-Risk DCIS after Breast Conserving Surgery: The Impact of a 7-Gene Biosignature BaseLocation: Room 6 B
Frank Vicini, MD, FASTRO – GenesisCare ### 1971959###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###GenesisCare###Presenter: – GenesisCare
### 8:10 AM – 8:17 AM PT
101 - Long Term Outcomes of Radiation (RT)-Monotherapy vs. Combined RT + Endocrine Therapy (RT+ET) in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older after Breast-Conserving Surgery (BCS)Location: Room 6 BPresenter: – Tumor Institute Radiation Oncology Group
Astrid Morris, MD, MS – Tumor Institute Radiation Oncology Group ### 1971960###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tumor Institute Radiation Oncology Group###Presenter: – Tumor Institute Radiation Oncology Group
### 8:20 AM – 8:27 AM PT
102 - Physician and Patient-Reported Outcomes of a Phase III Trial of Ultra-Hypofractionated vs. Moderate Hypofractionated Radiotherapy to the Whole Breast after Breast-Conserving SurgeryLocation: Room 6 BPresenter: – Mayo Clinic Arizona
Brady Laughlin, MD – Mayo Clinic Arizona ### 1971961###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Arizona###Presenter: – Mayo Clinic Arizona
### 8:30 AM – 8:37 AM PT
103 - Impact of Neoadjuvant Concurrent Chemoradiation (NACCRT) on Operability and Survival in Locally Advanced Inoperable Breast CancerLocation: Room 6 BPresenter: – Cancer Institute (WIA)
Priya Iyer, MD, RT, MBBS – Cancer Institute (WIA) ### 1971962###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Institute (WIA)###Presenter: – Cancer Institute (WIA)
### 8:40 AM – 8:47 AM PT
104 - Largest Real-World Data of Regional Nodal Irradiation Using Ultra-Hypofractionated 5-Fraction Adjuvant Radiation Therapy for Breast Cancer from a Single Institute in IndiaLocation: Room 6 BPresenter: – Tata Memorial Centre
Rajiv Sarin, MD, FRCR – Tata Memorial Centre ### 2010637###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tata Memorial Centre###Presenter: – Tata Memorial Centre
### 8:50 AM – 9:00 AM PT
DiscussantLocation: Room 6 BDiscussant: – Johns Hopkins University
Jean Wright, MD, FASTRO – Johns Hopkins University ### 524511###Discussant###Disclosures: Employment: Johns Hopkins University:Associate Professor, Radiation Oncology:Employee;National Institutes of Health:Associate Director, NINDS:Employee | Compensation: Up To Date: Other, Compensation Payment-End Date: present ;ASTRO: Other, Honoraria-End Date: present ;Oncospace: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Salary Support-End Date: present ;Prostate Cancer Foundation: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Salary Support-End Date: present ;Marshall Dennehy: Consultant, Compensation Payment-End Date: 9/22/22 ;Physicians Education Resource: Education Meeting Faculty, Honoraria, Travel Expenses-End Date: 3/3/2023 ;Elsevier Journals: Other, Honoraria-End Date: present | Ownership: none | Leadership: American Board of Radiology:Oral Board Examiner;ASTRO:Chair, Clinical Affairs and Quality Committee###Johns Hopkins University###Discussant: – Johns Hopkins University
### 8:00 AM – 8:07 AM PT
110 - STING-Dependent Sensing of Self-DNA Driving Pyroptosis Contributes to Radiation-Induced Lung InjuryLocation: Room 32Presenter: – Zhongshan Hospital Fudan University
Shisuo Du, MD, PhD – Zhongshan Hospital Fudan University ### 2130575###Presenter######Zhongshan Hospital Fudan University###Presenter: – Zhongshan Hospital Fudan University
### 8:10 AM – 8:17 AM PT
111 - Early and noninvasive PET imaging of radiation-induced lung injury by targeting CXCR4Location: Room 32Presenter: – Shandong Anti-Cancer Association
Jie Liu, MD – Shandong Anti-Cancer Association ### 1971968###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Anti-Cancer Association###Presenter: – Shandong Anti-Cancer Association
### 8:20 AM – 8:27 AM PT
112 - Subacute Cutaneous Toxicity with Single-Fraction Electron FLASH RT in Yorkshire SwineLocation: Room 32Presenter: – The University of Texas M.D. Anderson Cancer Center
Chike Abana, MD, PhD – The University of Texas M.D. Anderson Cancer Center ### 1971969###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The University of Texas M.D. Anderson Cancer Center###Presenter: – The University of Texas M.D. Anderson Cancer Center
### 8:30 AM – 8:37 AM PT
113 - Gut Microbiota-Derived D-Tagatose from EGCG Attenuates Radiation-Induced Intestinal InjuryLocation: Room 32Presenter: – The Second Affiliated Hospital of Soochow University
Haiyan Lu, MD – The Second Affiliated Hospital of Soochow University ### 1971970###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Second Affiliated Hospital of Soochow University###Presenter: – The Second Affiliated Hospital of Soochow University
### 8:30 AM – 8:37 AM PT
113 - Gut Microbiota-Derived D-Tagatose from EGCG Attenuates Radiation-Induced Intestinal InjuryLocation: Room 32Presenter: – The Second Affiliated Hospital of Soochow University
Ye Tian, MD – The Second Affiliated Hospital of Soochow University ### 2131439###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Second Affiliated Hospital of Soochow University###Presenter: – The Second Affiliated Hospital of Soochow University
### 8:40 AM – 8:47 AM PT
114 - HDAC-Mediated Glial Crosstalk Mediates Radiation Induced Memory Changes from Whole Brain Radiation in a Mouse ModelLocation: Room 32
Peter Mathen, MD – NIH/NCI ### 1971971###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NIH/NCI###Presenter: – NIH/NCI
### 8:50 AM – 9:00 AM PT
DiscussantLocation: Room 32
Deborah Citrin, MD, FASTRO – NIH/NCI ### 746662###Discussant###Disclosures: Employment: National Cancer Institute:Senior Investigator:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###NIH/NCI###Discussant: – NIH/NCI
### 8:00 AM – 8:07 AM PT
105 - Clinical Validation of HPV ctDNA for Early Detection of Residual Disease Following Chemoradiation in Cervical CancerLocation: Room 5Presenter: – Princess Margaret Cancer Center, University Health Network
Kathy Han, MD, MS – Princess Margaret Cancer Center, University Health Network ### 535931###Presenter###Disclosures: Employment: Princess Margaret Cancer Center, University Health Network:Radiation Oncologist:Employee | Compensation: Advisory Board: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: Oct 2021 ;Grants: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: March 2027 ;Princess Margaret Cancer Foundation: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Aug 2023 | Ownership: HPV ctDNA patent pending:Copyright | Leadership: CCTG:Endometrial Cancer Working Group Co-Chair###Princess Margaret Cancer Center, University Health Network###Presenter: – Princess Margaret Cancer Center, University Health Network
### 8:10 AM – 8:17 AM PT
106 - Prognostic Impact of Mismatch Repair Deficiency on Stage I-II Endometrioid Endometrial Cancer Treated with Adjuvant Radiation Therapy: A Multi-Institutional AnalysisLocation: Room 5Presenter: – Rutgers Cancer Institute of New Jersey
Zohaib Sherwani, MD – Rutgers Cancer Institute of New Jersey ### 1975183###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rutgers Cancer Institute of New Jersey###Presenter: – Rutgers Cancer Institute of New Jersey
### 8:20 AM – 8:27 AM PT
107 - HPV Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive ChemoradiationLocation: Room 5Presenter: – MD Anderson Cancer Center
Aaron Seo, MD, PhD – MD Anderson Cancer Center ### 1972798###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 8:30 AM – 8:37 AM PT
108 - A Cost-Effective, Machine Learning-Based New Unified Risk-Classification Score (NU-CATS) for Patients with Endometrial CancerLocation: Room 5Presenter: – Northwestern Feinberg School of Medicine
Shuhua Zheng, DO, PhD – Northwestern Feinberg School of Medicine ### 1972241###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwestern Feinberg School of Medicine###Presenter: – Northwestern Feinberg School of Medicine
### 8:40 AM – 8:47 AM PT
109 - Mutational Landscape of ER Receptor Negative Endometrial Cancer Patients Categorized as No Specific Molecular Profile (NSMP)Location: Room 5Presenter: – Washington University St. Louis
Michael Waters, MD, PhD – Washington University St. Louis ### 535929###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University St. Louis###Presenter: – Washington University St. Louis
### 8:50 AM – 9:00 AM PT
DiscussantLocation: Room 5Discussant: – Rutgers Cancer Institute of New Jersey
Lara Hathout, MD, FRCPC – Rutgers Cancer Institute of New Jersey ### 535936###Discussant###Disclosures: Employment: Rutgers Cancer Institute of New Jersey:Associate Professor:Employee | Compensation: RTOG Foundation: Consultant, Compensation Payment-End Date: to present | Ownership: none | Leadership: none###Rutgers Cancer Institute of New Jersey###Discussant: – Rutgers Cancer Institute of New Jersey
### 8:05 AM – 8:10 AM PT
1000 - Single Dose vs. Fractionated High-Dose Rate Brachytherapy in Localized Prostate Cancer: Long Term ResultsLocation: Room 8Presenter: – Mount Vernon Hospital
Peter Hoskin, MD – Mount Vernon Hospital ### 524448###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mount Vernon Hospital###Presenter: – Mount Vernon Hospital
### 8:10 AM – 8:15 AM PT
1002 - Long-Term Outcomes of Prospective Clinical Trial HDR-Brachytherapy Monotherapy in Single Day in Patients with Localizated Prostate CancerLocation: Room 8Presenter: – Genesiscare UK (Oxford)
Elena Moreno-Olmedo, MD – Genesiscare UK (Oxford) ### 1972040###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Genesiscare UK (Oxford)###Presenter: – Genesiscare UK (Oxford)
### 8:15 AM – 8:20 AM PT
1004 - Stereotactic Ablative Radiotherapy Boost to Bladder Tumor for Bladder Preservation in Patients with Muscle-Invasive Bladder CancerLocation: Room 8
Shang-Bin Qin, MD ### 747421###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 8:20 AM – 8:25 AM PT
1006 - Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled AnalysisLocation: Room 8Presenter: – Acibadem Adana Hospital
Gamze Ugurluer, MD – Acibadem Adana Hospital ### 535729###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Acibadem Adana Hospital###Presenter: – Acibadem Adana Hospital
### 8:20 AM – 8:25 AM PT
1006 - Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled AnalysisLocation: Room 8Presenter: – Acibadem Maslak Hospital
Enis Ozyar, MD – Acibadem Maslak Hospital ### 747976###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Acibadem Maslak Hospital###Presenter: – Acibadem Maslak Hospital
### 8:25 AM – 8:30 AM PT
1008 - Prospective Comparative Study of Quality of Life in Bladder Cancer Patients Undergoing Cystectomy or Bladder PreservationLocation: Room 8Presenter: – Tata Memorial Centre
Vedang Murthy, MD – Tata Memorial Centre ### 525244###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tata Memorial Centre###Presenter: – Tata Memorial Centre
### 8:30 AM – 8:40 AM PT
1010 - Prognostication of Overall Survival in Muscle Invasive Bladder Cancer: An Application of a Lymph Node Metastasis NomogramLocation: Room 8
Garrett Harada, MD – UCI Health ### 1972652###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCI Health###Presenter: – UCI Health
### 9:30 AM – 9:40 AM PT
3 - Consolidative Radiotherapy in Place of Autologous Stem Cell Transplant in Patients with Low-Risk Relapsed/Refractory (R/R) Classic Hodgkin Lymphoma (cHL) Treated with Nivolumab plus Brentuximab VedotiLocation: Ballroom 20Presenter: – Mayo Clinic Florida
Bradford Hoppe, MD, FASTRO, MPH – Mayo Clinic Florida ### 535819###Presenter###Disclosures: Employment: Mayo Clinic:Professor of Radiation Oncology:Employee | Compensation: Merck: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Remuneration Other-End Date: Present | Ownership: none | Leadership: PTCOG:Secretary;NRG lymphoma working group:Co-Chair###Mayo Clinic Florida###Presenter: – Mayo Clinic Florida
### 9:40 AM – 9:50 AM PT
4 - Association between Regular Vaginal Dilation and/or Sexual Activity and Long-Term Vaginal Morbidity in Cervical Cancer SurvivorsLocation: Ballroom 20Presenter: – Medical University of Vienna
Kathrin Kirchheiner, PhD, MSc – Medical University of Vienna ### 746728###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical University of Vienna###Presenter: – Medical University of Vienna
### 9:50 AM – 10:00 AM PT
5 - TROG 15.03/ANZUP International Multicenter Phase II Trial of Focal Ablative STereotactic RAdiotherapy for Cancers of the Kidney (FASTRACK II)Location: Ballroom 20Presenter: – Peter MacCallum Cancer Centre
Shankar Siva, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre ### 524764###Presenter###Disclosures: Employment: Peter MacCallum Cancer Centre:Radiation Oncologist:Employee | Compensation: AstraZeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Education Meeting Faculty, Remuneration Other-End Date: present ;Varian Medical Systems: Education Meeting Faculty, Research Grants, Research Funding, Research Salary Support, Remuneration Other-End Date: present ;Reflexion Medical Systems: Research Grants, Research Funding, Research Salary Support, Remuneration Other-End Date: 2022 | Ownership: none | Leadership: ART committee of IASLC:committee member;Radiosurgery Society (RSS):Board Directoy###Peter MacCallum Cancer Centre###Presenter: – Peter MacCallum Cancer Centre
### 10:00 AM – 10:10 AM PT
6 - Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate CancerLocation: Ballroom 20Presenter: – Duke University Medical Center
W. Robert Lee, MD, MS, FASTRO, MEd – Duke University Medical Center ### 524570###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University Medical Center###Presenter: – Duke University Medical Center
### 10:10 AM – 10:20 AM PT
7 - Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2Gy) vs. Standard Dose (70.2Gy) Radiation Therapy (RT) for Men with Localized Prostate CancerLocation: Ballroom 20Presenter: – Washington University St. Louis
Jeff Michalski, MD, MBA, FASTRO – Washington University St. Louis ### 1961865###Presenter###Disclosures: Employment: Washington University School of Medicine:Professor:Employee | Compensation: Michalski and Associates: Consultant, Travel Expenses, Compensation Payment-End Date: to present ;NCI: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present | Ownership: none | Leadership: NCI:Co-Chair;RTOG Foundation:Treasurer###Washington University St. Louis###Presenter: – Washington University St. Louis
### 10:20 AM – 10:30 AM PT
DiscussantLocation: Ballroom 20Discussant: – The Ohio State University
Dayssy Diaz Pardo, MD, MS – The Ohio State University ### 1974725###Discussant###Disclosures: Employment: The Ohio State University:Associate Professor:Employee | Compensation: ASCO: Education Meeting Faculty, Honoraria-End Date: 02/19/22 ;ASTRO: Education Meeting Faculty, Honoraria-End Date: 04/26/23 | Ownership: none | Leadership: The Ohio State University:Vice-Chair of DEI###The Ohio State University###Discussant: – The Ohio State University
### 10:20 AM – 10:30 AM PT
LBA 05 - Patient-Reported and Toxicity Results from the FABREC Study: A Multicenter Randomized Trial of Hypofractionated vs. Conventionally-Fractionated Postmastectomy Radiation Therapy After Implant-Based RecLocation: Ballroom 20Presenter: – Dana-Farber Cancer Institute
Rinaa Punglia, MD, FASTRO, MPH – Dana-Farber Cancer Institute ### 524819###Presenter###Disclosures: Employment: DFCI/BWH:Attending physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Dana-Farber Cancer Institute###Presenter: – Dana-Farber Cancer Institute
### 10:30 AM – 10:40 AM PT
LBA 06 - Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in Men with High-Risk Biochemically Recurrent Prostate Cancer and Prior Radiotherapy: EMBARK Subgroup AnalysisLocation: Ballroom 20Presenter: – Calvary Mater Newcastle Hospital
Swetha Sridharan, MBBS – Calvary Mater Newcastle Hospital ### 2105487###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Calvary Mater Newcastle Hospital###Presenter: – Calvary Mater Newcastle Hospital
### 10:40 AM – 10:50 AM PT
LBA 07 - Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy for Patients with 1-10 Brain Metastases from Small Cell Lung Cancer: Results of the Randomized ENCEPHALON (ARO 2018-9) TrialLocation: Ballroom 20Presenter: – Technical University of Munich (TUM), Radiation Oncology
Denise Bernhardt, MD – Technical University of Munich (TUM), Radiation Oncology ### 1972263###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Technical University of Munich (TUM), Radiation Oncology###Presenter: – Technical University of Munich (TUM), Radiation Oncology
### 4:50 PM – 4:55 PM PT
1012 - Development and Evaluation of a Mobile App for Radiotherapy Patient EducationLocation: Room 8Presenter: – Hospital Universitario
Jose Felipe Munoz Lozano, MD – Hospital Universitario ### 1972042###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Universitario###Presenter: – Hospital Universitario
### 4:55 PM – 5:00 PM PT
1014 - Association of Parental Status and Gender with Burden of Multidisciplinary Tumor BoardsLocation: Room 8
Brittney Chau, MD – USC ### 1972043###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###USC###Presenter: – USC
### 5:00 PM – 5:05 PM PT
1016 - Teaching Trainees to be Effective Mentors: A Needs-Based Assessment in Radiation OncologyLocation: Room 8Presenter: – Brigham and Women's Hospital/Dana-Farber
Anurag Saraf, MD – Brigham and Women's Hospital/Dana-Farber ### 537850###Presenter###Disclosures: Employment: Brigham Womens Hospital:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Brigham and Women's Hospital/Dana-Farber###Presenter: – Brigham and Women's Hospital/Dana-Farber
### 5:05 PM – 5:10 PM PT
1018 - Quality of Life In Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-LinacLocation: Room 8Presenter: – Medical College of Wisconsin
Sara Beltran Ponce, MD – Medical College of Wisconsin ### 538557###Presenter###Disclosures: Employment: Medical College of Wisconsin Affiliated Hospitals:Resident Physician:Employee | Compensation: American College of Radiation Oncology: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 11/2023 | Ownership: none | Leadership: Society for Women in Radiation Oncology:Vice Chair###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 5:10 PM – 5:15 PM PT
1020 - A Randomized Standard-of-Care Controlled Trial of Xenogeneic Platelet-Rich Plasma Lotion to Reduce Acute Radiation Dermatitis in Breast Cancer PatientsLocation: Room 8Presenter: – Tri-Service General Hospital
Chun-Shu Lin, MD, PhD – Tri-Service General Hospital ### 537922###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tri-Service General Hospital###Presenter: – Tri-Service General Hospital
### 5:15 PM – 5:20 PM PT
1022 - Harnessing Electronic Patient-Reported Outcomes (ePRO) in Routine Care to Promote Clinical Trial Enrollment: A Randomized StudyLocation: Room 8Presenter: – Tufts University School of Medicine
Nicholas Verdini, BS – Tufts University School of Medicine ### 1972044###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tufts University School of Medicine###Presenter: – Tufts University School of Medicine
### 4:45 PM – 4:52 PM PT
115 - Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-Gastric Diseases (PROCEED): Assessment of Pathologic Response in a Prospective, Phase II Single-Arm TrialLocation: Room 1Presenter: – Duke Cancer Institute
Pooja Karukonda, MD – Duke Cancer Institute ### 525023###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke Cancer Institute###Presenter: – Duke Cancer Institute
### 4:55 PM – 5:02 PM PT
116 - Prospective Trial of Using Imaging to Predict Pathologic Response and Clinical Outcomes in Locally Advanced Esophageal CancerLocation: Room 1Presenter: – City of Hope
Yufei Liu, MD, PhD – City of Hope ### 1971972###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope###Presenter: – City of Hope
### 5:05 PM – 5:12 PM PT
117 - Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma: A Randomized Phase II Clinical TrialLocation: Room 1Presenter: – Zhejiang Cancer Hospital
Yang Yang, MD, DO, PhD – Zhejiang Cancer Hospital ### 1971973###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Zhejiang Cancer Hospital###Presenter: – Zhejiang Cancer Hospital
### 5:15 PM – 5:22 PM PT
118 - Electrocardiogram with Artificial Intelligence Assessment as a Predictor of Cardiac Events and Overall Survival in Patients Receiving Radiotherapy for Esophageal CancerLocation: Room 1Presenter: – Mayo Clinic College of Medicine and Science Rochester
Roman Kowalchuk, MD, BS – Mayo Clinic College of Medicine and Science Rochester ### 1971974###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic College of Medicine and Science Rochester###Presenter: – Mayo Clinic College of Medicine and Science Rochester
### 5:25 PM – 5:32 PM PT
119 - Utilization of the Triangle Volume in Patients with Localized PDAC Undergoing Pre-Operative SBRT: Report of Early OutcomesLocation: Room 1Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Serena Mao, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 1971975###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 5:35 PM – 5:42 PM PT
120 - Patterns of locoregional failure after ablative 5-fraction stereotactic MR-guided on-table adaptive radiation therapy for pancreatic cancerLocation: Room 1Presenter: – Miami Cancer Institute
Michael Chuong, MD – Miami Cancer Institute ### 525437###Presenter###Disclosures: Employment: Baptist Health South Florida:physician:Employee | Compensation: ViewRay: Consultant, Research Grants, Research Funding, Research Salary Support, Speaker's Bureau, Grant Research Funding, Honoraria, Travel Expenses, In-kind Donations, Compensation Payment-End Date: to present ;Novocure: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;StratPharma: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Sirtex: Speaker's Bureau, Honoraria-End Date: to present | Ownership: none | Leadership: Proton Collaborative Group:Board of Directors member###Miami Cancer Institute###Presenter: – Miami Cancer Institute
### 5:45 PM – 5:55 PM PT
DiscussantLocation: Room 1Discussant: – Cedars-Sinai Medical Center
Katelyn Atkins, MD, PhD – Cedars-Sinai Medical Center ### 535835###Discussant###Disclosures: Employment: Cedars-Sinai Medical Center:Assistant Professor:Employee | Compensation: OncLive: Education Meeting Faculty, Honoraria-End Date: 04/2021 | Ownership: none | Leadership: none###Cedars-Sinai Medical Center###Discussant: – Cedars-Sinai Medical Center
### 4:45 PM – 4:52 PM PT
127 - Deep Learning-Based Natural Language Processing to Automate Esophagitis Severity Grading from the Electronic Health RecordsLocation: Room 32Presenter: – Harvard Medical School
Shan Chen, MS – Harvard Medical School ### 1975156###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Medical School###Presenter: – Harvard Medical School
### 4:55 PM – 5:02 PM PT
128 - Operational Ontology for Radiation Oncology (OORO): A Professional Society-Based, Multi-Stakeholder Consensus Driven Informatics Standard Supporting Clinical and Research Use of Real-World DataLocation: Room 32
Amanda Caissie ### 2149159###Presenter#########Presenter:
### 5:05 PM – 5:12 PM PT
129 - A Prospective Study of Machine Learning-Assisted Radiotherapy Planning for Patients Receiving 54 Gy to the BrainLocation: Room 32Presenter: – Princess Margaret Cancer Centre
Derek Tsang, MD, MS – Princess Margaret Cancer Centre ### 525202###Presenter###Disclosures: Employment: University Health Network:Radiation Oncologist:Employee | Compensation: Elekta: Education Meeting Faculty, Travel Expenses-End Date: 12/2022 | Ownership: none | Leadership: none###Princess Margaret Cancer Centre###Presenter: – Princess Margaret Cancer Centre
### 5:15 PM – 5:22 PM PT
130 - Curietherapy User eXperience Pilot Study: A Novel Augmented Reality Educational Tool during Radiation Oncology Consultation for Patients with Breast CancerLocation: Room 32Presenter: – NYU Grossman School of Medicine
David Byun, MD – NYU Grossman School of Medicine ### 747830###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU Grossman School of Medicine###Presenter: – NYU Grossman School of Medicine
### 5:25 PM – 5:32 PM PT
131 - Improving Dose Volume Histogram (DVH) Based Analysis of Clinical Outcomes Using Modern Statistical Techniques: A Systematic Answer to Multiple Comparisons ConcernsLocation: Room 32Presenter: – Mayo Clinic Arizona
Mirek Fatyga, PhD – Mayo Clinic Arizona ### 536051###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Arizona###Presenter: – Mayo Clinic Arizona
### 5:35 PM – 5:42 PM PT
132 - Clinical Acceptability of Artificial Intelligence-Screened Interstitial Lung Disease (AI-ILD) in Lung Cancer Patients Treated with RadiotherapyLocation: Room 32Presenter: – University of Toronto
Nicholas McNeil, MBBS – University of Toronto ### 1975157###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Toronto###Presenter: – University of Toronto
### 5:45 PM – 5:55 PM PT
DiscussantLocation: Room 32Discussant: – Brigham and Women's Hospital
Danielle Bitterman, MD – Brigham and Women's Hospital ### 538515###Discussant###Disclosures: Employment: Brigham and Women's Hospital:Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: HemOnc.org:Associate Editor, Radiation Oncology###Brigham and Women's Hospital###Discussant: – Brigham and Women's Hospital
### 4:45 PM – 4:52 PM PT
121 - Building a Diverse Pathway into Radiation Oncology: The Initial 12-Year Experience of the ASTRO Medical Student Fellowship Program for Underrepresented PopulationsLocation: Room 4Presenter: – Stanford Health Care
Kekoa Taparra, MD, PhD – Stanford Health Care ### 535869###Presenter###Disclosures: Employment: Stanford Health Care:Resident Physician:Employee | Compensation: Lancet: Other, Honoraria-End Date: 6/2022 ;Stanford CARE: Other, Honoraria-End Date: 3/2023 ;MDACC: Other, Honoraria-End Date: 5/2023 | Ownership: none | Leadership: none###Stanford Health Care###Presenter: – Stanford Health Care
### 4:55 PM – 5:02 PM PT
122 - The Impact of a Precision Medicine Navigator on Inequities Associated with Utilization of Genomic Tests in Black Men with Prostate CancerLocation: Room 4Presenter: – University of Maryland Medical Center
Alexander Allen, MD – University of Maryland Medical Center ### 1972178###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland Medical Center###Presenter: – University of Maryland Medical Center
### 5:05 PM – 5:12 PM PT
123 - Improving Sexual Orientation and Gender Identity Documentation at an NCI-Designated Comprehensive Cancer CenterLocation: Room 4Presenter: – NYU Langone Laura and Isaac Perlmutter Cancer Center
Jason Domogauer, MD, PhD – NYU Langone Laura and Isaac Perlmutter Cancer Center ### 525196###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU Langone Laura and Isaac Perlmutter Cancer Center###Presenter: – NYU Langone Laura and Isaac Perlmutter Cancer Center
### 5:15 PM – 5:22 PM PT
124 - State Mandatory Paid Family Leave and Survival among Children with CancerLocation: Room 4Presenter: – Washington University School of Medicine
Justin Barnes, MD, MS – Washington University School of Medicine ### 595915###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University School of Medicine###Presenter: – Washington University School of Medicine
### 5:25 PM – 5:32 PM PT
125 - Under-Representation for Female Cancers in Commercial Auto-Segmentation Solutions and Open-Source Imaging DatasetsLocation: Room 4Presenter: – Memorial Sloan Kettering Cancer Center
Maria Thor, PhD, MS – Memorial Sloan Kettering Cancer Center ### 535996###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 5:35 PM – 5:42 PM PT
126 - Impact of Free Hospital-Provided Rideshare Service on Radiation Therapy Completion Rates: A Matched Cohort AnalysisLocation: Room 4Presenter: – University Hospitals Seidman Cancer Center
Eric Chen, MD – University Hospitals Seidman Cancer Center ### 1975179###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospitals Seidman Cancer Center###Presenter: – University Hospitals Seidman Cancer Center
### 5:45 PM – 5:55 PM PT
DiscussantLocation: Room 4Discussant: – Dana-Farber/Brigham and Women's Cancer Center
Idalid Franco, MD, MPH – Dana-Farber/Brigham and Women's Cancer Center ### 854606###Discussant###Disclosures: Employment: Brigham and Women's Hospital Dana-Farber CC:Radiation Oncologist:Employee | Compensation: Diversity Supplement, National Cancer Institute: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;NIH/NCI Loan Repayment Program: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;Brigham and Women's Hospital Dana-Farber CC: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: Present | Ownership: none | Leadership: Association of Residents in Radiation Oncology:Executive Vice Chair;American Society of Radiation Oncology ASTRO:Vice Chair###Dana-Farber/Brigham and Women's Cancer Center###Discussant: – Dana-Farber/Brigham and Women's Cancer Center
### - Monday, October 2, 2023
8:10 AM – 8:17 AM PT
134 - Cell-Free DNA Fragmentomics for Early Detection of Malignant Transformation in NF1 Patients Harboring Plexiform NeurofibromasLocation: Room 4Presenter: – Washington University in St. Louis
Aadel Chaudhuri, MD, PhD – Washington University in St. Louis ### 524821###Presenter###Disclosures: Employment: Washington University in St. Louis:Assistant Professor:Employee | Compensation: Roche: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria, Travel Expenses, Compensation Payment-End Date: Present ;Tempus Labs: Consultant, Grant Research Funding, Compensation Payment-End Date: Present ;Geneoscopy: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Remuneration Other-End Date: Present ;Illumina: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: Present ;Daiichi Sankyo: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: Present ;AstraZeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: Present ;AlphaSights: Consultant, Compensation Payment-End Date: Present ;DeciBio: Consultant, Compensation Payment-End Date: Present ;Guidepoint: Consultant, Compensation Payment-End Date: Present ;Dava Oncology: Education Meeting Faculty, Honoraria-End Date: 8/2021 ;NuProbe: Consultant, Compensation Payment-End Date: 11/2021 | Ownership: Geneoscopy:Stock Options;Droplet Biosciences:Ownership Equity;LiquidCell Dx Inc.:Ownership Equity;Patent filings related to cancer biomarkers:Copyright | Leadership: Translational Lung Cancer Research:Editorial Board;Molecular Diagnosis & Therapy:Editorial Board;NIH Liquid Biopsy Interest Group:Co-Chair;Siteman Cancer Center ctDNA Working Group:Leader;NSCLC Multidisciplinary Advisory Council:Member of the advisory council###Washington University in St. Louis###Presenter: – Washington University in St. Louis
### 8:20 AM – 8:27 AM PT
135 - Proteogenomic Analysis of Human Uterine Cervical Cancer (UCC) Reveals Treatment-Resistant Subtypes of UCCLocation: Room 4Presenter: – National Cancer Center
Joo-Young Kim, MD, PhD – National Cancer Center ### 1971976###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center###Presenter: – National Cancer Center
### 8:30 AM – 8:37 AM PT
136 - Prognostic Significance of Pretreatment Immune Cell Infiltration in Muscle Invasive Bladder Cancer Treated with Definitive Chemoradiation: Analysis of NRG RTOG 0524 and 0712Location: Room 4Presenter: – Rutgers University
Matthew Deek, MD – Rutgers University ### 524839###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rutgers University###Presenter: – Rutgers University
### 8:40 AM – 8:47 AM PT
137 - Concurrent Radiation and Immunotherapy Augments Local Immunity and Improves Survival in Aneuploid NSCLCLocation: Room 4Presenter: – University of Chicago Pritzker School of Medicine
Liam Spurr, BS – University of Chicago Pritzker School of Medicine ### 1971977###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Chicago Pritzker School of Medicine###Presenter: – University of Chicago Pritzker School of Medicine
### 8:50 AM – 8:57 AM PT
138 - Comprehensive Genomic Analysis Stratified by KRAS Status in Patients with Pancreatic Adenocarcinoma and Its Prognostic SignificanceLocation: Room 4Presenter: – Rutgers Cancer Institute of New Jersey
Jongmyung Kim, MD, PhD – Rutgers Cancer Institute of New Jersey ### 1971978###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rutgers Cancer Institute of New Jersey###Presenter: – Rutgers Cancer Institute of New Jersey
### 8:05 AM – 8:10 AM PT
1024 - Synthetic MRI-Assisted and Self-Supervised Adaptive Segmentation of Organs-at-Risk (OARs) in MRI-Based Radiation TherapyLocation: Room 8Presenter: – The Institute of Cancer Research
Reza Kalantar, PhD, MS, BS – The Institute of Cancer Research ### 1972045###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Institute of Cancer Research###Presenter: – The Institute of Cancer Research
### 8:10 AM – 8:15 AM PT
1026 - Crowdsourcing Deep Learning Algorithms to Automatically Contour GI Luminal Organs on Serial MRIsLocation: Room 8Presenter: – University of Calgary
Sangjune Lee, MD, MS, BS, FRCPC DABR – University of Calgary ### 537913###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Calgary###Presenter: – University of Calgary
### 8:15 AM – 8:20 AM PT
1028 - Contouring Analysis on Synthetic Contrast-Enhanced MR from GRMM-GAN and Implications on MR-Guide Radiation TherapyLocation: Room 8Presenter: – University of California San Francisco
Wensha Yang, PhD – University of California San Francisco ### 538240###Presenter###Disclosures: Employment: University of California, San Francisco:Associate Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 8:20 AM – 8:25 AM PT
1030 - Deep Learning-Based Pipeline for Automatic Identification of Intestinal Regenerating Crypts in Mouse Histological ImagesLocation: Room 8Presenter: – University of Washington
Jie Fu, PhD – University of Washington ### 746641###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 8:25 AM – 8:30 AM PT
1032 - Towards Automated Dosimetric Analysis of the Bladder Trigone: Deep-Learning-Based Joint Segmentation and Landmark LocalizationLocation: Room 8
Hengjie Liu, BS – UCLA ### 1972047###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA###Presenter: – UCLA
### 8:30 AM – 8:35 AM PT
1034 - Organ Specific Deep Learning-Based Correction of Inaccurate Auto-Segmentation on Abdominal MRILocation: Room 8Presenter: – Medical College of Wisconsin
Christina Sarosiek, PhD – Medical College of Wisconsin ### 1972048###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 10:50 AM – 10:55 AM PT
1048 - A Prospective Study Evaluating Sexual Health Outcomes in Patients Undergoing (Chemo)Radiation (CRT/RT) for Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC)Location: Room 7Presenter: – Princess Alexandra Hospital
Lachlan Joseph McDowell, MB, BS, MBBS, FRANZCR – Princess Alexandra Hospital ### 2010635###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Alexandra Hospital###Presenter: – Princess Alexandra Hospital
### 10:55 AM – 11:00 AM PT
1050 - Patient-Reported Outcomes Evaluating the Impact of Hypo-Fractionated Palliative Quadshot Radiotherapy and Concurrent CDDP Treatment on Health-Related Quality of Life in Patients with Locally Advanced Location: Room 7Presenter: – All India Institute of Medical Sciences
Jhansi Pattanaik, MD, MBBS – All India Institute of Medical Sciences ### 1972056###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###All India Institute of Medical Sciences###Presenter: – All India Institute of Medical Sciences
### 11:00 AM – 11:05 AM PT
1052 - Hearing Outcomes in Cisplatin or Cetuximab Combined with Radiation for Patients with HPV-Associated Oropharyngeal Cancer in NRG/RTOG 1016Location: Room 7Presenter: – Medical College of Wisconsin
Christina Runge, PhD – Medical College of Wisconsin ### 1972057###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 11:05 AM – 11:10 AM PT
1054 - Natural History and Clinical/Dosimetric Determinants of Osteoradionecrosis in a Large Cohort of Head and Neck Cancer Following Curative Radiotherapy: Debunking the Myth of Decreased Rates of OsteoradiLocation: Room 7Presenter: – MD Anderson Cancer Center
Abdallah Mohamed, MD, PhD – MD Anderson Cancer Center ### 525110###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 11:10 AM – 11:15 AM PT
1056 - Long-Term Outcomes of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell CarcinomaLocation: Room 7Presenter: – University of North Carolina at Chapel Hill
Ryan Morse, MD – University of North Carolina at Chapel Hill ### 537838###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of North Carolina at Chapel Hill###Presenter: – University of North Carolina at Chapel Hill
### 11:15 AM – 11:20 AM PT
1058 - Brachial Plexus Tolerance to Standard Fractionation Re-Irradiation: The Ohio State University ExperienceLocation: Room 7Presenter: – The James Cancer Hospital & Solove Research Institute
Khaled Dibs, MD – The James Cancer Hospital & Solove Research Institute ### 1972058###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The James Cancer Hospital & Solove Research Institute###Presenter: – The James Cancer Hospital & Solove Research Institute
### 10:55 AM – 11:00 AM PT
1038 - TFAM Modulates Cardiomyocytes Pyroptosis Induced by Ionizing Radiation through mtDNA/TLR9/NF-kB PathwayLocation: Room 8Presenter: – Shandong Cancer Hospital and Institute
Guoxin Cai, MD – Shandong Cancer Hospital and Institute ### 747344###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 11:00 AM – 11:05 AM PT
1042 - Single-Cell RNA Sequencing Reveals a Subset of cMAS can Aggravate RIHD through CXCL1-CXCR2 AxisLocation: Room 8
Dawei Chen, MD, MB ### 2029570###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 11:05 AM – 11:10 AM PT
1044 - HPK1 Inhibition Enhances HXRT Anti-Tumor Immune Response by Regulating RGS16 to Restore Functionality in Tumor-Infiltrating Exhausted CD8+T CellsLocation: Room 8
Dawei Chen, MD, MB ### 2029570###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 11:10 AM – 11:15 AM PT
1046 - Bifunctional Role of Monocyte Subsets in Modulating Radiotherapy Combined Intra-Tumor aCD40 Agonist Induced Abscopal EffectLocation: Room 8
Yue Zhao, MD, PhD – China ### 1975191###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###China###Presenter: – China
### 10:45 AM – 10:52 AM PT
151 - Dosimetry Reconstruction in Radiopharmaceutical Therapy Using a Sparse Network of External ?-SensorsLocation: Room 30 A/B/CPresenter: – University of California, Berkeley
Rahul Lall, BS – University of California, Berkeley ### 1971979###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, Berkeley###Presenter: – University of California, Berkeley
### 10:55 AM – 11:02 AM PT
152 - Long-Term Results of a Multi-Institutional Study of Dynamic Tumor Tracking-Stereotactic Body Radiotherapy for Lung TumorsLocation: Room 30 A/B/CPresenter: – Kindai University Faculty of Medicine
Yukinori Matsuo, MD, PhD – Kindai University Faculty of Medicine ### 1971980###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kindai University Faculty of Medicine###Presenter: – Kindai University Faculty of Medicine
### 11:05 AM – 11:12 AM PT
153 - Assessment of Dynamic Contrast Enhanced (DCE) MRI for Detection of Radiotherapy Induced Alteration in Mandibular VasculatureLocation: Room 30 A/B/CPresenter: – MD Anderson Cancer Center
Moamen Abobakr, MD – MD Anderson Cancer Center ### 1971981###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 11:15 AM – 11:22 AM PT
154 - Theranostic Nanoparticle Uptake in Patient Brain Tumors as Quantified by MP2RAGE T1 MappingLocation: Room 30 A/B/CPresenter: – Massachusetts General Brigham
Stephanie Bennett, PhD – Massachusetts General Brigham ### 1971982###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Massachusetts General Brigham###Presenter: – Massachusetts General Brigham
### 11:25 AM – 11:32 AM PT
155 - The Microvascular Health Status Predicts Radio-Induced Acute Toxicities in Breast, Prostate and Head and Neck Cancer PatientsLocation: Room 30 A/B/CPresenter: – Fondazione IRCCS - Istituto Nazionale dei Tumori
Tiziana Rancati, MS – Fondazione IRCCS - Istituto Nazionale dei Tumori ### 747410###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fondazione IRCCS - Istituto Nazionale dei Tumori###Presenter: – Fondazione IRCCS - Istituto Nazionale dei Tumori
### 11:35 AM – 11:42 AM PT
156 - Auto-Correction for Inaccurate Auto-Segmentation of Abdominal MRI by Combining Deep Learning and Active Contour MethodLocation: Room 30 A/B/CPresenter: – Medical College of Wisconsin
Mohammad Zarenia, PhD – Medical College of Wisconsin ### 1971983###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 10:45 AM – 10:52 AM PT
145 - Prospective Phase II Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy (SBRT) Followed By Concurrent Mediastinal Chemoradiation and Adjuvant Immunotherapy for Locally-Advanced Non-Small Location: Room 6 D/EPresenter: – Southeast Radiation Oncology Group PA
John Heinzerling, MD, OCN – Southeast Radiation Oncology Group PA ### 524541###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Southeast Radiation Oncology Group PA###Presenter: – Southeast Radiation Oncology Group PA
### 10:55 AM – 11:02 AM PT
146 - Adaptive Radiotherapy Guided by PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Phase II Randomized StudyLocation: Room 6 D/EPresenter: – Shanghai Pulmonary Hospital
Yaoyao Zhu, MS, RT – Shanghai Pulmonary Hospital ### 2065895###Presenter######Shanghai Pulmonary Hospital###Presenter: – Shanghai Pulmonary Hospital
### 10:55 AM – 11:02 AM PT
146 - Adaptive Radiotherapy Guided by PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Phase II Randomized StudyLocation: Room 6 D/EPresenter: – Shanghai Pulmonary Hospital
Yaping Xu, PhD – Shanghai Pulmonary Hospital ### 535769###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shanghai Pulmonary Hospital###Presenter: – Shanghai Pulmonary Hospital
### 11:05 AM – 11:12 AM PT
147 - Assessment of Precision Irradiation in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease (ASPIRE-ILD): Primary Analysis of a Phase II TrialLocation: Room 6 D/EPresenter: – London Health Sciences Centre
David Palma, MD, PhD – London Health Sciences Centre ### 524579###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###London Health Sciences Centre###Presenter: – London Health Sciences Centre
### 11:15 AM – 11:22 AM PT
148 - Dosimetric Impact of Systematic Mediastinal Staging via Endobronchial Ultrasound for Patients with Locally Advanced Lung Cancer: The SEISMIC TrialLocation: Room 6 D/EPresenter: – Peter MacCallum Cancer Centre
Shankar Siva, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre ### 524764###Presenter###Disclosures: Employment: Peter MacCallum Cancer Centre:Radiation Oncologist:Employee | Compensation: AstraZeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Education Meeting Faculty, Remuneration Other-End Date: present ;Varian Medical Systems: Education Meeting Faculty, Research Grants, Research Funding, Research Salary Support, Remuneration Other-End Date: present ;Reflexion Medical Systems: Research Grants, Research Funding, Research Salary Support, Remuneration Other-End Date: 2022 | Ownership: none | Leadership: ART committee of IASLC:committee member;Radiosurgery Society (RSS):Board Directoy###Peter MacCallum Cancer Centre###Presenter: – Peter MacCallum Cancer Centre
### 11:25 AM – 11:32 AM PT
149 - Circulating Tumor DNA for Early Risk Stratification of Oligometastatic Lung CancerLocation: Room 6 D/EPresenter: – Washington University in St. Louis
Aadel Chaudhuri, MD, PhD – Washington University in St. Louis ### 524821###Presenter###Disclosures: Employment: Washington University in St. Louis:Assistant Professor:Employee | Compensation: Roche: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria, Travel Expenses, Compensation Payment-End Date: Present ;Tempus Labs: Consultant, Grant Research Funding, Compensation Payment-End Date: Present ;Geneoscopy: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Remuneration Other-End Date: Present ;Illumina: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: Present ;Daiichi Sankyo: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: Present ;AstraZeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: Present ;AlphaSights: Consultant, Compensation Payment-End Date: Present ;DeciBio: Consultant, Compensation Payment-End Date: Present ;Guidepoint: Consultant, Compensation Payment-End Date: Present ;Dava Oncology: Education Meeting Faculty, Honoraria-End Date: 8/2021 ;NuProbe: Consultant, Compensation Payment-End Date: 11/2021 | Ownership: Geneoscopy:Stock Options;Droplet Biosciences:Ownership Equity;LiquidCell Dx Inc.:Ownership Equity;Patent filings related to cancer biomarkers:Copyright | Leadership: Translational Lung Cancer Research:Editorial Board;Molecular Diagnosis & Therapy:Editorial Board;NIH Liquid Biopsy Interest Group:Co-Chair;Siteman Cancer Center ctDNA Working Group:Leader;NSCLC Multidisciplinary Advisory Council:Member of the advisory council###Washington University in St. Louis###Presenter: – Washington University in St. Louis
### 11:35 AM – 11:42 AM PT
150 - Residual ctDNA Detection Predicts Benefit From Definitive Chemoradiotherapy and Immune Checkpoint Inhibitors in Locally Advanced NSCLCLocation: Room 6 D/EPresenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
Yu Wang, MD – Chinese Academy of Medical Sciences and Peking Union Medical College ### 1971999###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
### 11:45 AM – 11:55 AM PT
DiscussantLocation: Room 6 D/EDiscussant: – University of Pennsvania Radiation Oncology
Jeffrey Bradley, MD, FASTRO – University of Pennsvania Radiation Oncology ### 524838###Discussant###Disclosures: Employment: Emory School of Medicine:Professor:Employee | Compensation: Mevion Medical Systems, Inc: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Uncompensated-End Date: to present ;Varian, Inc: Consultant, Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present ;Genentech, Inc: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: to present ;AstraZeneca, Inc: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Travel Expenses-End Date: to present | Ownership: none | Leadership: none###University of Pennsvania Radiation Oncology###Discussant: – University of Pennsvania Radiation Oncology
### 10:45 AM – 10:52 AM PT
139 - Quality of Life Results of Addition of Androgen Deprivation Therapy and Pelvic Lymph Node Treatment to Prostate Bed Salvage Radiotherapy: NRG Oncology/RTOG 0534 SPPORTLocation: Room 6 C/FPresenter: – Nell Hodgson Woodruff School of Nursing
Deborah Bruner, PhD, RN, FAAN – Nell Hodgson Woodruff School of Nursing ### 524661###Presenter###Disclosures: Employment: Emory University:Senior Vice President for Research:Employee | Compensation: ASTRO: Other, Honoraria-End Date: present ;Center for Global Health Initiative - Atlanta GA: Other, Uncompensated-End Date: present ;Flatiron Health: Consultant, Compensation Payment-End Date: 05/21/2022 ;Memorial Sloan Kettering Cancer Center: Other, Honoraria-End Date: 01/18/2022 ;National Cancer Institute: Other, Travel Expenses-End Date: present ;NRG Oncology Executive Advisory Board: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Travel Expenses, Remuneration Other-End Date: present ;Oncology Nursing Society: Other, Honoraria-End Date: 04/29/2021 ;PROTEUS Consortium: Other, Uncompensated-End Date: present ;U.S. Global Leadership Coalition: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Other, Uncompensated-End Date: present ;Wilmont Cancer Center: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: present | Ownership: Abbvie:Other;Bristol-Myers Squibb:Other;GlaxoSmithKline:Other;Johnson & Johnson:Other;Pfizer:Other;Proctor & Gamble:Other;Stryker Corp.:Other;Walgreens Boots Alliance:Other | Leadership: none###Nell Hodgson Woodruff School of Nursing###Presenter: – Nell Hodgson Woodruff School of Nursing
### 10:45 AM – 12:00 PM PT
DiscussantLocation: Room 6 C/FDiscussant: – University of Montreal Hospital (CHUM)
Cynthia Menard, MD – University of Montreal Hospital (CHUM) ### 524471###Discussant###Disclosures: Employment: CHUM:Department Chief:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Montreal Hospital (CHUM)###Discussant: – University of Montreal Hospital (CHUM)
### 10:55 AM – 11:02 AM PT
140 - Final Analysis of a Phase III Controlled Randomized Study of Stereotactic Body Proton Therapy or Conventionally Fractionated Proton Therapy for Early Prostate Cancer: PCG GU002Location: Room 6 C/FPresenter: – Mayo Clinic Arizona
Diego Toesca, MD – Mayo Clinic Arizona ### 537606###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Arizona###Presenter: – Mayo Clinic Arizona
### 11:05 AM – 11:12 AM PT
141 - Conventional vs. Hypo-Fractionated, Radiotherapy for High-Risk Prostate Cancer (PCS5), Randomized, Non-Inferiority, Phase 3 Trial: Posthoc Analysis of IMRT vs. 3D-CRT Radiation Therapy Associated ToxiLocation: Room 6 C/FPresenter: – McGill University Health Centre
Constanza Martinez, MD, PhD – McGill University Health Centre ### 1972566###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGill University Health Centre###Presenter: – McGill University Health Centre
### 11:15 AM – 11:22 AM PT
142 - Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High Risk Adenocarcinoma of the Prostate Location: Room 6 C/FPresenter: – McGill University
Tamim Niazi, MD – McGill University ### 524755###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGill University###Presenter: – McGill University
### 11:25 AM – 11:32 AM PT
143 - Progression-Directed Therapy in Oligoprogressive Castration-Refractory Prostate Cancer: Results of the Prospective Single-Arm Phase II MEDCARE TrialLocation: Room 6 C/F
Gert De Meerleer, MD, PhD – UZ Leuven ### 2086546###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UZ Leuven###Presenter: – UZ Leuven
### 11:35 AM – 11:42 AM PT
144 - The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B StudyLocation: Room 6 C/FPresenter: – Royal Marsden NHS Foundation Trust
Ragu Ratnakumaran, MBBS – Royal Marsden NHS Foundation Trust ### 1972022###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Royal Marsden NHS Foundation Trust###Presenter: – Royal Marsden NHS Foundation Trust
### 1:30 PM – 1:40 PM PT
LBA 04 - Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)Location: Ballroom 20Presenter: – Northwestern Medicine Cancer Center Warrenville and Proton Center
Vinai Gondi, MD – Northwestern Medicine Cancer Center Warrenville and Proton Center ### 524455###Presenter###Disclosures: Employment: Radiation Oncology Consultants, LLC:Physician Partner:Partner | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Northwestern Medicine Cancer Center Warrenville and Proton Center###Presenter: – Northwestern Medicine Cancer Center Warrenville and Proton Center
### 1:40 PM – 1:50 PM PT
DiscussantLocation: Ballroom 20Discussant: – MD Anderson Cancer Center
Debra Yeboa, MD – MD Anderson Cancer Center ### 747057###Discussant###Disclosures: Employment: Univ of Texas MD Anderson Cancer Center:Associate Professor:Employee | Compensation: Practical Radiation Oncology Journal: Other, Uncompensated-End Date: present ;Robert Wood Johnson: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Brockman Foundation/ Medical research Grant: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;MD Anderson Institutional Research Grant Funding: Grant Research Funding-End Date: to present | Ownership: none | Leadership: Society of Neuro-Oncology:Radiation Sciences Co-chair;Radiosurgery Society (RSS):Annual Planning Committee member & MD Anderson liason###MD Anderson Cancer Center###Discussant: – MD Anderson Cancer Center
### 1:50 PM – 2:00 PM PT
1 - High Dose Hyperfractionated Thoracic Radiotherapy vs. Standard Dose for Limited Stage Small-Cell Lung Cancer: A Multicenter, Open-Label Randomized, Phase 3 TrialLocation: Ballroom 20Presenter: – Peking University Cancer Hospital and Institute
Jiayi Yu, PhD – Peking University Cancer Hospital and Institute ### 2082532###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking University Cancer Hospital and Institute###Presenter: – Peking University Cancer Hospital and Institute
### 2:00 PM – 2:10 PM PT
DiscussantLocation: Ballroom 20Discussant: – Winship Cancer Institute of Emory University
Kristin Higgins, MD – Winship Cancer Institute of Emory University ### 525180###Discussant###Disclosures: Employment: Emory Healthcare:Medical Director:Employee | Compensation: Astra Zeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant-End Date: to present ;RefleXion Medical: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: to present ;Janssen Pharmaceuticals: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Compensation Payment-End Date: to present ;Genentech: Consultant-End Date: to present ;Jazz Pharmaceuticals: Research Grants, Research Funding, Research Salary Support, Salary Support-End Date: to present | Ownership: none | Leadership: NRG Oncology:General DIrector###Winship Cancer Institute of Emory University###Discussant: – Winship Cancer Institute of Emory University
### 2:10 PM – 2:20 PM PT
LBA 03 - 5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated ExteLocation: Ballroom 20Presenter: – The Royal Marsden NHS Foundation Trust
Nicholas van As, MD, MB – The Royal Marsden NHS Foundation Trust ### 2105488###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Royal Marsden NHS Foundation Trust###Presenter: – The Royal Marsden NHS Foundation Trust
### 2:20 PM – 2:30 PM PT
DiscussantLocation: Ballroom 20Discussant: – Princess Margaret Cancer Centre
Alejandro Berlin, MD, MS – Princess Margaret Cancer Centre ### 538171###Discussant###Disclosures: Employment: University Health Network:Radiation Oncologist, Clinician-Scientist:Employee | Compensation: NRG Oncology: Research Grants, Research Funding, Research Salary Support, Uncompensated-End Date: to present | Ownership: none | Leadership: none###Princess Margaret Cancer Centre###Discussant: – Princess Margaret Cancer Centre
### 2:30 PM – 2:40 PM PT
LBA 01 - Randomized Phase III Trial of Postoperative Radiotherapy with or without Cetuximab for Intermediate-Risk Squamous Cell Carcinoma of the Head and Neck (SCCHN): NRG/RTOG 0920Location: Ballroom 20Presenter: – Penn State Hershey Medical Center
Mitchell Machtay, MD, FASTRO – Penn State Hershey Medical Center ### 516024###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Penn State Hershey Medical Center###Presenter: – Penn State Hershey Medical Center
### 2:40 PM – 2:50 PM PT
LBA 02 - Randomized Controlled Trial of Hypofractionated vs. Normo-fractionated Accelerated Radiation Therapy with or without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO)Location: Ballroom 20Presenter: – University of Maryland School of Medicine
Soren Bentzen, DSc, PhD, FASTRO – University of Maryland School of Medicine ### 524521###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland School of Medicine###Presenter: – University of Maryland School of Medicine
### 2:50 PM – 3:00 PM PT
DiscussantLocation: Ballroom 20Discussant: – Baylor College of Medicine
Christina Chapman, MD, MS – Baylor College of Medicine ### 535694###Discussant###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Baylor College of Medicine###Discussant: – Baylor College of Medicine
### 3:00 PM – 3:07 PM PT
157 - Peripheral T-Cell Priming and Micrometastatic Disease Control with Metastasis-Directed Therapy: Multidimensional Immunogenomic Profiling of Oligometastatic Prostate Cancer in the EXTEND TrialLocation: Room 6 D/EPresenter: – University of Texas MD Anderson Cancer Center
Alexander Sherry, MD – University of Texas MD Anderson Cancer Center ### 747082###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Texas MD Anderson Cancer Center###Presenter: – University of Texas MD Anderson Cancer Center
### 3:10 PM – 3:17 PM PT
158 - Validation of a Genomic Classifier in the NRG Oncology/RTOG 0521 Phase III Trial of Docetaxel with Androgen Suppression and Radiotherapy for Localized High-Risk Prostate CancerLocation: Room 6 D/EPresenter: – The Mayo Clinic
Ryan Phillips, MD, PhD – The Mayo Clinic ### 525253###Presenter###Disclosures: Employment: The Mayo Clinic:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###The Mayo Clinic###Presenter: – The Mayo Clinic
### 3:20 PM – 3:27 PM PT
159 - Cross-Comparison Individual Patient Level Analysis of Three Gene Expression Signatures in Localized Prostate in over 50,000 MenLocation: Room 6 D/EPresenter: – Case Western Reserve University/University Hospitals Cleveland Medical Center
Angela Jia, MD, PhD – Case Western Reserve University/University Hospitals Cleveland Medical Center ### 850161###Presenter###Disclosures: Employment: University Hospitals, Seidman Cancer Center, Case Western Reserve University:Radiation Oncologist, Assistant Professor in Radiation Oncology:Employee | Compensation: Myovant: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria, Travel Expenses-End Date: 12/2022 | Ownership: none | Leadership: none###Case Western Reserve University/University Hospitals Cleveland Medical Center###Presenter: – Case Western Reserve University/University Hospitals Cleveland Medical Center
### 3:30 PM – 3:37 PM PT
160 - Detection Rate of 18F-rhPSMA-7.3 PET in Patients with Suspected Prostate Cancer Recurrence at PSA Levels <1 ng/mL: Data from the Phase 3 SPOTLIGHT StudyLocation: Room 6 D/EPresenter: – Emory University
Ashesh Jani, MD, FASTRO – Emory University ### 524753###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University###Presenter: – Emory University
### 3:40 PM – 3:47 PM PT
161 - PSMA-Positive Extracellular Vesicles Predict Disease Recurrence in Oligometastatic Castration-Sensitive Prostate Cancer Treated with Stereotactic Ablative Radiotherapy: Analysis of the ORIOLE trialLocation: Room 6 D/E
Edlira Horjeti, MD, MBBS – Mayo Clinic ### 1971984###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic###Presenter: – Mayo Clinic
### 3:50 PM – 4:00 PM PT
DiscussantLocation: Room 6 D/EDiscussant: – MD Anderson Cancer Center
Osama Mohamad, MD, PhD – MD Anderson Cancer Center ### 525386###Discussant###Disclosures: Employment: Md Anderson cancer center, houston:Assistant professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###MD Anderson Cancer Center###Discussant: – MD Anderson Cancer Center
### 3:00 PM – 3:07 PM PT
173 - Combination of BET Inhibition with Radiation Induces Anti-Tumor Immune Response in Pre-Clinical Models of ER-Positive Breast CancerLocation: Room 30 D/EPresenter: – UT Southwestern Medical Center at Dallas
Prasanna Alluri, MD, PhD – UT Southwestern Medical Center at Dallas ### 537644###Presenter###Disclosures: Employment: UT Southwestern Medical Center:Assistant Professor:Employee | Compensation: Department of Defense: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;METAvivor: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 05/31/2025 | Ownership: none | Leadership: UT Southwestern Breast Center:Member, Breast Program Leadership Committee;UT Southwestern Breast Center:Member###UT Southwestern Medical Center at Dallas###Presenter: – UT Southwestern Medical Center at Dallas
### 3:10 PM – 3:17 PM PT
174 - CRISPR-Based Epigenome Editing and Genome Wide Screening Define Mediators of Chemotherapy Response in GlioblastomaLocation: Room 30 D/E
S. John Liu, MD, PhD – UCSF ### 747161###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSF###Presenter: – UCSF
### 3:20 PM – 3:27 PM PT
175 - In Silico Discovery and Investigation of Novel Small Molecules Targeting PSMA7 for the Treatment of GBMLocation: Room 30 D/EPresenter: – The Ohio State University
Christian Showalter, PhD – The Ohio State University ### 1971985###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Ohio State University###Presenter: – The Ohio State University
### 3:30 PM – 3:37 PM PT
176 - Targeting Tri-Methyl-Histone H3 (Lys27) in Rectal Cancer: A Novel Strategy to Enhance Radiosensitivity and Predict Response to Neoadjuvant TherapyLocation: Room 30 D/EPresenter: – UAMS Radiation Oncology
Anam Kesaria, MD – UAMS Radiation Oncology ### 1971986###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UAMS Radiation Oncology###Presenter: – UAMS Radiation Oncology
### 3:40 PM – 3:47 PM PT
177 - Targeting Non-Kinase Function of CDK6 to Overcome CDK4/6 Inhibitor ResistanceLocation: Room 30 D/EPresenter: – UT Southwestern Medical Center at Dallas
Prasanna Alluri, MD, PhD – UT Southwestern Medical Center at Dallas ### 537644###Presenter###Disclosures: Employment: UT Southwestern Medical Center:Assistant Professor:Employee | Compensation: Department of Defense: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;METAvivor: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 05/31/2025 | Ownership: none | Leadership: UT Southwestern Breast Center:Member, Breast Program Leadership Committee;UT Southwestern Breast Center:Member###UT Southwestern Medical Center at Dallas###Presenter: – UT Southwestern Medical Center at Dallas
### 3:50 PM – 3:57 PM PT
178 - Nanobody-Based ImmunoPET for Hepatocellular CarcinomaLocation: Room 30 D/EPresenter: – National Cancer Institute
Stanley Fayn, BS – National Cancer Institute ### 1971987###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Institute###Presenter: – National Cancer Institute
### 3:00 PM – 3:07 PM PT
168 - Short Course Adjuvant Vaginal Cuff Brachytherapy (VCB) in Early Endometrial Cancer: Primary Endpoint Results of the SAVE Randomized Clinical TrialLocation: Room 31Presenter: – University of Utah Huntsman Cancer Institute
Gita Suneja, MD, MS – University of Utah Huntsman Cancer Institute ### 552886###Presenter###Disclosures: Employment: University of Utah:Associate Professor:Employee | Compensation: NIH/NCI: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 9/2023 ;American Brachytherapy Society: Education Meeting Faculty, Uncompensated-End Date: 2/2022 ;American College of Radiation Oncology: Education Meeting Faculty, Travel Expenses-End Date: 3/2023 ;Binaytara Foundation: Education Meeting Faculty, Travel Expenses-End Date: 4/2023 | Ownership: none | Leadership: Radiation Oncology Institute:Vice-Chair###University of Utah Huntsman Cancer Institute###Presenter: – University of Utah Huntsman Cancer Institute
### 3:10 PM – 3:17 PM PT
169 - Toripalimab Combined with Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma Patients: Early Results of Safety and FeasibilityLocation: Room 31
Dan Ou, MD ### 1975175###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:20 PM – 3:27 PM PT
170 - Evaluating the Effects of Bone Marrow Sparing Radiotherapy on Acute Hematologic Toxicity for Patients with Locoregionally Advanced Cervical Cancer: A Prospective Phase II Randomized Controlled TrialLocation: Room 31Presenter: – West China Second University Hospital
Wen Li, PhD candidate – West China Second University Hospital ### 1975176###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###West China Second University Hospital###Presenter: – West China Second University Hospital
### 3:30 PM – 3:37 PM PT
171 - HYPOCx-iRex (TCTR20210812003) A Phase II RCT: 44Gy/20F VS 45Gy/25F CCRT in Cervical Cancer - 6-mo Post-RT UpdateLocation: Room 31Presenter: – Siriraj Hospital Mahidol University
Tissana Prasartseree, MD – Siriraj Hospital Mahidol University ### 1975177###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Siriraj Hospital Mahidol University###Presenter: – Siriraj Hospital Mahidol University
### 3:40 PM – 3:47 PM PT
172 - Multiple Sessions vs. Single Session Image-Based Intracavitary Brachytherapy for Locally Advanced Cervical Cancer - A Randomized Control TrialLocation: Room 31Presenter: – AIIMS New Delhi
Daya Nand Sharma, MD, PhD – AIIMS New Delhi ### 2143441###Presenter######AIIMS New Delhi###Presenter: – AIIMS New Delhi
### 3:48 PM – 3:58 PM PT
DiscussantLocation: Room 31Discussant: – University of Colorado Anschutz Medical Campus
Katherine Tzou, MD – University of Colorado Anschutz Medical Campus ### 1975178###Discussant###Disclosures: Employment: University of Colorado:Associate Professor of Radiation Oncology:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Colorado Anschutz Medical Campus###Discussant: – University of Colorado Anschutz Medical Campus
### 3:00 PM – 3:07 PM PT
162 - Radiochemical Oxygen Depletion Depends on Chemical Environment and Dose-Rate: Implications for FLASH EffectLocation: Room 30 A/B/CPresenter: – University of Pennsylvania
Rodney Wiersma, PhD – University of Pennsylvania ### 1972011###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 3:10 PM – 3:17 PM PT
163 - A Novel Planning and Delivery Technology: Dose, Dose Rate and Linear Energy Transfer(LET) Optimization Based on Spot-Scanning Proton Arc Therapy FLASH (SPLASHLET)Location: Room 30 A/B/CPresenter: – Beaumont Health System
Gang Liu, PhD – Beaumont Health System ### 1972012###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beaumont Health System###Presenter: – Beaumont Health System
### 3:10 PM – 3:17 PM PT
163 - A Novel Planning and Delivery Technology: Dose, Dose Rate and Linear Energy Transfer(LET) Optimization Based on Spot-Scanning Proton Arc Therapy FLASH (SPLASHLET)Location: Room 30 A/B/CPresenter: – William Beaumont Hospital
Xiaoqiang Li, PhD – William Beaumont Hospital ### 746630###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###William Beaumont Hospital###Presenter: – William Beaumont Hospital
### 3:20 PM – 3:27 PM PT
164 - An Effective Dose Rate Optimization Algorithm for Efficient Conventional-Dose-Rate Proton Therapy and Ultra-High-Dose-Rate FLASH Proton TherapyLocation: Room 30 A/B/CPresenter: – University of Kansas Medical Center
Yuting Lin, PhD – University of Kansas Medical Center ### 2122124###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 3:30 PM – 3:37 PM PT
165 - Towards Clinical Proton Minibeam Radiation Therapy (pMBRT): Development of Clinical pMBRT System Prototype and pMBRT-Specific Treatment Planning MethodLocation: Room 30 A/B/CPresenter: – University of Kansas Medical Center
Hao Gao, PhD – University of Kansas Medical Center ### 746653###Presenter###Disclosures: Employment: University of Kansas:Associate Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 3:40 PM – 3:47 PM PT
166 - Towards Clinical Translation of Microbeam Radiation Therapy (MRT) with a Compact SourceLocation: Room 30 A/B/C
Stefan Bartzsch, PhD ### 1973077###Presenter#########Presenter:
### 3:50 PM – 3:57 PM PT
167 - Spot Scanning Proton Therapy for Pregnant Patients with Brain and Head and Neck TumorsLocation: Room 30 A/B/C
Justine Dupere, PhD – Mayo Clinic ### 1972015###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic###Presenter: – Mayo Clinic
### 3:05 PM – 3:10 PM PT
1060 - Implementation Outcomes of Strategies to Promote Short-Course Radiation for Nonspine Bone Metastases in an Academic-Community Partnership: Survey Results from the ALIGNMENT TrialLocation: Room 8Presenter: – Memorial Sloan Kettering Cancer Center
Patricia Santos, MD, MS – Memorial Sloan Kettering Cancer Center ### 1972063###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 3:15 PM – 3:20 PM PT
1064 - Patient and Caregivers Opinions on Receiving Radiology Results before Oncologist AppointmentsLocation: Room 8Presenter: – City of Hope National Medical Center
Nicholas Eustace, MD, PhD, BS – City of Hope National Medical Center ### 1972064###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 3:20 PM – 3:25 PM PT
1066 - Do Physician Patient Sharing Networks Impact Disparities in Access to Multidisciplinary Cancer Consultation for Early Stage Lung Cancer? A SEER-Medicare Network AnalysisLocation: Room 8Presenter: – Dartmouth-Hitchcock Medical Center
Nirav Kapadia, MD, MS – Dartmouth-Hitchcock Medical Center ### 1961860###Presenter###Disclosures: Employment: Dartmouth Health:Associate Professor of Medicine (Radiation Oncology):Employee;Alison Kapadia:Assistant Professor Emergency Medicine:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: Northern New England Clinical Oncology Society:Treasurer; Board/Executive Committee Member###Dartmouth-Hitchcock Medical Center###Presenter: – Dartmouth-Hitchcock Medical Center
### 3:25 PM – 3:30 PM PT
1068 - Multi-Institutional Fact-Finding Study: Association between Geriatric Assessment and Reduction in Intensity of Radiotherapy for Elderly Cancer Patients without MetastasisLocation: Room 8Presenter: – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Keiko Murofushi, MD, PhD – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital ### 1972065###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital###Presenter: – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
### 3:30 PM – 3:35 PM PT
1070 - Radiotherapy Access and Treatment in Rwanda: Demographics and Clinical Characteristics of Cervical Cancer PatientsLocation: Room 8Presenter: – Albert Einstein College of Medicine
Timothy Davis, BS – Albert Einstein College of Medicine ### 1972066###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Albert Einstein College of Medicine###Presenter: – Albert Einstein College of Medicine
### 5:00 PM – 5:07 PM PT
179 - Is it the Type of Axillary Surgery or the Number of Removed Lymph Nodes That Increases the Risk of Breast Cancer Related Lymphedema (BCRL)? Results from a Prospective Screening TrialLocation: Room 6 C/FPresenter: – Massachusetts General Hospital
George Naoum, MD, MS – Massachusetts General Hospital ### 535714###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 5:09 PM – 5:16 PM PT
180 - Increased Complication Rates with Proton Therapy in Breast Cancer Patients with Immediate, Implant-Based Reconstruction: Single-Institution Comparative Effectiveness AnalysisLocation: Room 6 C/FPresenter: – Massachusetts General Hospital
Alphonse Taghian, MD, PhD, FASTRO – Massachusetts General Hospital ### 524513###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 5:18 PM – 5:25 PM PT
181 - Risk of Radiation-Associated Secondary Malignancies Among Patients with Breast Cancer Harboring TP53 Germline VariantsLocation: Room 6 C/FPresenter: – Memorial Sloan Kettering Cancer Center
Gustav Cederquist, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1972756###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 5:27 PM – 5:34 PM PT
182 - Early Results of the French Multicenter, Randomized SHARE Trial Comparing Whole Breast Irradiation vs. Accelerated Partial Breast Irradiation in Postmenopausal Women with Early-Stage Breast CancerLocation: Room 6 C/FPresenter: – Henri Mondor University Hospital and Faculte de Medecin de Creteil Paris XII
Yazid Belkacemi, MD, PhD – Henri Mondor University Hospital and Faculte de Medecin de Creteil Paris XII ### 525052###Presenter######Henri Mondor University Hospital and Faculte de Medecin de Creteil Paris XII###Presenter: – Henri Mondor University Hospital and Faculte de Medecin de Creteil Paris XII
### 5:36 PM – 5:43 PM PT
183 - Comparison between Pre-Pectoral and Post-Pectoral Implant Reconstruction and Different Radiation Modalities on Breast Reconstruction ComplicationsLocation: Room 6 C/FPresenter: – Massachusetts General Hospital
George Naoum, MD, MS – Massachusetts General Hospital ### 535714###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 5:45 PM – 5:52 PM PT
184 - Effectiveness and Toxicity of Five Fraction Prone Accelerated Partial Breast IrradiationLocation: Room 6 C/FPresenter: – NYU Grossman School of Medicine
Camille Hardy Abeloos, MD – NYU Grossman School of Medicine ### 1972367###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU Grossman School of Medicine###Presenter: – NYU Grossman School of Medicine
### 5:54 PM – 5:58 PM PT
DiscussantLocation: Room 6 C/FDiscussant: – University of Colorado Denver
Rachel Rabinovitch, MD, FASTRO – University of Colorado Denver ### 524443###Discussant###Disclosures: Employment: University of Colorado Hospital:Professor:Employee | Compensation: Prelude: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Uncompensated-End Date: present | Ownership: Abbott Laboratories:Stock;Bristol-Myers Squibb:Stock;Intuitive Surgical:Stock;Pfizer:Stock;Zimmer Biomet:Stock | Leadership: none###University of Colorado Denver###Discussant: – University of Colorado Denver
### 5:54 PM – 6:00 PM PT
DiscussantLocation: Room 6 C/FDiscussant: – Johns Hopkins University
Jean Wright, MD, FASTRO – Johns Hopkins University ### 524511###Discussant###Disclosures: Employment: Johns Hopkins University:Associate Professor, Radiation Oncology:Employee;National Institutes of Health:Associate Director, NINDS:Employee | Compensation: Up To Date: Other, Compensation Payment-End Date: present ;ASTRO: Other, Honoraria-End Date: present ;Oncospace: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Salary Support-End Date: present ;Prostate Cancer Foundation: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Salary Support-End Date: present ;Marshall Dennehy: Consultant, Compensation Payment-End Date: 9/22/22 ;Physicians Education Resource: Education Meeting Faculty, Honoraria, Travel Expenses-End Date: 3/3/2023 ;Elsevier Journals: Other, Honoraria-End Date: present | Ownership: none | Leadership: American Board of Radiology:Oral Board Examiner;ASTRO:Chair, Clinical Affairs and Quality Committee###Johns Hopkins University###Discussant: – Johns Hopkins University
### 5:00 PM – 5:07 PM PT
191 - Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphomas: An ILROG Multi-Institutional StudyLocation: Room 31Presenter: – University of Pennsylvania Health System
Nikhil Yegya-Raman, MD – University of Pennsylvania Health System ### 538407###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania Health System###Presenter: – University of Pennsylvania Health System
### 5:10 PM – 5:17 PM PT
192 - Phase I Trial of Re-Priming Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after Chimeric Antigen Receptor T-Cell (CAR-T) TherapyLocation: Room 31Presenter: – UT Southwestern Medical Center
Kiran Kumar, MD, MBA – UT Southwestern Medical Center ### 1971996###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 5:20 PM – 5:27 PM PT
193 - Consolidative Radiotherapy for Residual PET-Avid Disease on Day +30 Post CAR T-Cell Therapy in Non-Hodgkin LymphomaLocation: Room 31Presenter: – Mayo Clinic Florida
Omran Saifi, MD – Mayo Clinic Florida ### 1971997###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Florida###Presenter: – Mayo Clinic Florida
### 5:30 PM – 5:37 PM PT
194 - Prognostic Significance of Positron Emission Tomography Delta Radiomics Following Bridging Therapy in Patients with Large B-Cell Lymphoma Undergoing CAR T-Cell TherapyLocation: Room 31Presenter: – City of Hope National Medical Center
Colton Ladbury, MD, BS – City of Hope National Medical Center ### 747995###Presenter###Disclosures: Employment: City of Hope National Medical Center:Resident Physician:Employee | Compensation: RefleXion Medical: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 5:40 PM – 5:47 PM PT
195 - Characterization of Lymphopenia during Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Patients with Aggressive B Cell LymphomasLocation: Room 31Presenter: – MD Anderson Cancer Center
Gohar Manzar, MD, PhD – MD Anderson Cancer Center ### 537790###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 5:50 PM – 6:00 PM PT
DiscussantLocation: Room 31Discussant: – Yale Therapeutic Radiology
Timothy Robinson, MD, PhD – Yale Therapeutic Radiology ### 1996488###Discussant###Disclosures: Employment: Yale:Assistant Professor:Employee | Compensation: Kite Pharma: Consultant, Honoraria-End Date: Ongoing | Ownership: Duke University:Copyright;H. Lee Moffitt Cancer Center:Copyright | Leadership: Yale:Co-Leader###Yale Therapeutic Radiology###Discussant: – Yale Therapeutic Radiology
### 5:00 PM – 5:07 PM PT
185 - Real Time Volumetric MRI for MR-Guided 3D Motion Tracking via Sparse Prior-Augmented Neural Representation LearningLocation: Room 1Presenter: – Stanford University
Lianli Liu, PhD – Stanford University ### 1974818###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 5:10 PM – 5:17 PM PT
186 - Heatmaps to Assess Tumor Motion Probability with MRcine in Head and Neck CancerLocation: Room 1Presenter: – Miami Cancer Institute
Yonatan Weiss, MD – Miami Cancer Institute ### 538461###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Miami Cancer Institute###Presenter: – Miami Cancer Institute
### 5:20 PM – 5:27 PM PT
187 - Principal Component Analysis to Design Planning Target Volume in Oropharyngeal CancersLocation: Room 1Presenter: – UT Southwestern Medical Center
Mona Arbab, MD, M.Ed – UT Southwestern Medical Center ### 537709###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 5:30 PM – 5:37 PM PT
188 - Reduction of Late Urinary Toxicity from Prostate Cancer Radiotherapy via Intrafractional MV-kV Image GuidanceLocation: Room 1Presenter: – Memorial Sloan Kettering Cancer Center
Pengpeng Zhang, PhD – Memorial Sloan Kettering Cancer Center ### 537982###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 5:40 PM – 5:47 PM PT
189 - Deep Learning-Based Single-View Fluorescence Dose Reconstruction for 3D DosimetryLocation: Room 1Presenter: – Stanford University
Yusuke Nomura, PhD – Stanford University ### 1975182###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 5:50 PM – 5:57 PM PT
190 - Deep Learning-Based Automated Quality Assurance for Palliative Spinal Treatment Planning in RadiotherapyLocation: Room 1Presenter: – Brigham and Women's Hospital/Dana-Farber
Christopher Kehayias, PhD – Brigham and Women's Hospital/Dana-Farber ### 1975181###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Brigham and Women's Hospital/Dana-Farber###Presenter: – Brigham and Women's Hospital/Dana-Farber
### 5:05 PM – 5:10 PM PT
1072 - PD-L1 Inhibitors Combined with Thoracic Radiotherapy in First-Line Treatment of Extensive Stage Small Cell Lung Cancer: A Propensity Score-Matched, Real-World StudyLocation: Room 8
Jianfeng Peng, PhD ### 1972068###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:10 PM – 5:15 PM PT
1074 - Progression-Free Survival As a Surrogate Endpoint of Overall Survival in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy: Trial-Level Meta-Analysis and IndividLocation: Room 8Presenter: – Johns Hopkins University
Chen Hu, PhD – Johns Hopkins University ### 790140###Presenter###Disclosures: Employment: Johns Hopkins University:Associate Professor:Employee | Compensation: D1Med Technology Co. Ltd: Consultant, Honoraria-End Date: to present | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 5:15 PM – 5:20 PM PT
1076 - Early Stereotactic Body Radiotherapy to the Primary Lung Lesion for Patients with Advanced NSCLC Treated with First-Line Systemic TherapyLocation: Room 8Presenter: – Chongqing University Cancer Hospital
Dan Tao, MD – Chongqing University Cancer Hospital ### 1972069###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chongqing University Cancer Hospital###Presenter: – Chongqing University Cancer Hospital
### 5:20 PM – 5:25 PM PT
1078 - Treatment Efficacy Outcomes Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Survival Analysis of a Phase IB trialLocation: Room 8Presenter: – University of Wisconsin
Brett Morris, MD, PhD – University of Wisconsin ### 525241###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin###Presenter: – University of Wisconsin
### 5:25 PM – 5:30 PM PT
1080 - Genomic Signature for Oligometastatic Disease in Non-Small Cell Lung Cancer Patients with Brain MetastasesLocation: Room 8Presenter: – Wake Forest Baptist Medical Center
Ariel Choi, MD – Wake Forest Baptist Medical Center ### 1972070###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Wake Forest Baptist Medical Center###Presenter: – Wake Forest Baptist Medical Center
### 5:00 PM – 6:00 PM PT
2599 - Determining the Minimal Clinically Important Difference of the FACT-E to Evaluate the Change in the Quality of Life of Patients with Esophageal Cancer Treated with Curative RadiotherapyLocation: Hall B1Presenter: – IZ Statistics LLC
Isabella Zaniletti, PhD – IZ Statistics LLC ### 1972428###Presenter######IZ Statistics LLC###Presenter: – IZ Statistics LLC
### - Tuesday, October 3, 2023
8:00 AM – 8:07 AM PT
213 - Polymetastatic Recurrence-Free Survival in Patients with Repeat Oligometastases on the SABR-5 TrialLocation: Room 4Presenter: – BC Cancer - Vancouver Centre
Wei Liu, MD – BC Cancer - Vancouver Centre ### 537497###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###BC Cancer - Vancouver Centre###Presenter: – BC Cancer - Vancouver Centre
### 8:10 AM – 8:17 AM PT
214 - Multi-Institutional Validation of the Recursive Partitioning Analysis for Overall Survival in Patients Undergoing Spine Radiosurgery for Spine MetastasisLocation: Room 4Presenter: – University of Iowa Hospitals and Clinics
Sami Koro, MD – University of Iowa Hospitals and Clinics ### 1975152###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Iowa Hospitals and Clinics###Presenter: – University of Iowa Hospitals and Clinics
### 8:20 AM – 8:27 AM PT
215 - Predictors of Hepatotoxicity in Patients with Metastatic Solid Tumors Treated with Immune Checkpoint Inhibition (ICI) and Liver-Directed SBRTLocation: Room 4Presenter: – University of Chicago
Connor Lynch, MD – University of Chicago ### 746582###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Chicago###Presenter: – University of Chicago
### 8:30 AM – 8:37 AM PT
216 - Prompt Pain Relief: Advanced Practice Provider Led Rapid Access Palliative Radiotherapy ClinicLocation: Room 4Presenter: – Mayo Clinic Florida
Michelle Wear, MSN – Mayo Clinic Florida ### 1975154###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Florida###Presenter: – Mayo Clinic Florida
### 8:40 AM – 8:47 AM PT
217 - Provider Perceptions of a Novel Inpatient Co-Rounding Model Integrating Medical Oncology, Neuro-Oncology, and Radiation Oncology for the Care of Patients with Advanced CancerLocation: Room 4Presenter: – University of California San Francisco
Lisa Ni, MD – University of California San Francisco ### 538130###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 8:50 AM – 9:00 AM PT
DiscussantLocation: Room 4Discussant: – Beth Israel Deaconess Medical Center
Lauren Hertan, MD, MS – Beth Israel Deaconess Medical Center ### 746701###Discussant###Disclosures: Employment: Beth Israel Deaconess Medical Center:Physician:Employee;Beth Israel Deaconess Medical Center:Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Beth Israel Deaconess Medical Center###Discussant: – Beth Israel Deaconess Medical Center
### 8:00 AM – 8:07 AM PT
208 - 30 Gy vs. 45 Gy Consolidative Thoracic Radiation (cTRT) for Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Multicenter, Randomized, Phase 3 TrialLocation: Room 6 C/FPresenter: – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Nan Bi, MD, PhD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ### 584248###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
### 8:10 AM – 8:17 AM PT
209 - Thoracic Radiotherapy Improves the Outcomes of Extensive Stage Small-Cell Lung Cancer Patients Receiving First-Line Immunotherapy: A Multicenter Retrospective AnalysisLocation: Room 6 C/FPresenter: – Shandong Cancer Hospital and Institute
Linlin Wang, MD, PhD – Shandong Cancer Hospital and Institute ### 1975167###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 8:20 AM – 8:27 AM PT
210 - A Multicentered, Randomized Phase ? Study of Definitive vs. Palliative Radiotherapy to Primary Tumor for Stage ? Non-Small Cell Lung Cancer with Less than Three Metastatic Organs: CSWOG ChinaLocation: Room 6 C/FPresenter: – The Affiliated Hospital of Guizhou Medical University
Geng Yichao, MD – The Affiliated Hospital of Guizhou Medical University ### 2037789###Presenter###Disclosures: Employment: Affiliated Hospital of Guizhou Medical University:Attending physician:Employee;Affiliated Cancer Hospital of Guizhou Medical University:Attending physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###The Affiliated Hospital of Guizhou Medical University###Presenter: – The Affiliated Hospital of Guizhou Medical University
### 8:30 AM – 8:37 AM PT
211 - Stereotactic Ablative Radiotherapy for Oligo-Progressive Cancers: Results of the Randomized Phase II STOP TrialLocation: Room 6 C/FPresenter: – BC Cancer - Vancouver Centre
Devin Schellenberg, MD, BS – BC Cancer - Vancouver Centre ### 1975169###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###BC Cancer - Vancouver Centre###Presenter: – BC Cancer - Vancouver Centre
### 8:40 AM – 8:45 AM PT
212 - Safety and Efficacy Analysis of Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated with SHR-1316 Plus Chemotherapy and Sequential Chest Radiotherapy as First-Line Therapy from a PhLocation: Room 6 C/FPresenter: – Shandong Cancer Hospital and Institute
Linlin Wang, MD, PhD – Shandong Cancer Hospital and Institute ### 1975167###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 8:48 AM – 8:58 AM PT
DiscussantLocation: Room 6 C/FDiscussant: – Mayo Clinic Rochester
Dawn Owen, MD, PhD – Mayo Clinic Rochester ### 525127###Discussant###Disclosures: Employment: Mayo Clinic:Physician:Employee | Compensation: Astra Zeneca: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Varian: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;UptoDate: Other, Honoraria-End Date: present | Ownership: none | Leadership: none###Mayo Clinic Rochester###Discussant: – Mayo Clinic Rochester
### 8:00 AM – 8:07 AM PT
202 - Multitask AI Models for the Joint Prediction of Overall Survival, Progression-Free Survival, and Death without Progression as a Composite Endpoint for LA-NSCLC Patients Treated with ChemoradiotherapyLocation: Room 2Presenter: – University of Pennsylvania
Sang Ho Lee, PhD – University of Pennsylvania ### 1971988###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 8:10 AM – 8:17 AM PT
203 - Deployment of a Deep Learning Automated Cardiac Sub-Structure Contouring Algorithm to Measure Coronary Dose Exposure Trends in Lung Cancer Radiation TherapyLocation: Room 2Presenter: – Brigham and Womens Hopsital
Christian Guthier, PhD, MS – Brigham and Womens Hopsital ### 536013###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Brigham and Womens Hopsital###Presenter: – Brigham and Womens Hopsital
### 8:20 AM – 8:27 AM PT
204 - Dynamic Prediction of Toxicities in Head and Neck Cancer Radiotherapy by 3D Convolutional Neural Network Using Daily Cone-Beam CTsLocation: Room 2Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
Chulmin Bang, MD – Centre Hospitalier de l'Universite de Montreal (CHUM) ### 1971989###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Centre Hospitalier de l'Universite de Montreal (CHUM)###Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
### 8:30 AM – 8:37 AM PT
205 - Deep Learning for Automatic Prediction of Lymph Node Station Metastasis in Esophageal Cancer Patients from Contrast-Enhanced CTLocation: Room 2Presenter: – Sichuan Cancer Hospital and Institute
Qifeng Wang, MD, PhD – Sichuan Cancer Hospital and Institute ### 2094333###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 8:40 AM – 8:47 AM PT
206 - Machine Parameter Optimization of a Clinical Linear Accelerator Using Deep Reinforcement Learning for Automatic Generation of Deliverable Prostate VMAT PlansLocation: Room 2Presenter: – Johns Hopkins University
William Hrinivich, PhD – Johns Hopkins University ### 748017###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 8:50 AM – 8:57 AM PT
207 - Clinico-Genomics Model to Predict Survival in Non-Metastatic Breast Cancer: Comparing the Performance of Machine Learning ModelsLocation: Room 2Presenter: – Rush University Medical Center
Adrianna Cueto-Marquez, MD, BS – Rush University Medical Center ### 1971990###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rush University Medical Center###Presenter: – Rush University Medical Center
### 8:05 AM – 8:10 AM PT
1278 - Real-Time 3D Liver Tumor Localization via Combined Optical Surface Imaging and an X-Ray Projection from Arbitrary Imaging AnglesLocation: Room 8Presenter: – University of Texas Southwestern Medical Center
Hua-Chieh Shao, PhD – University of Texas Southwestern Medical Center ### 1973155###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Texas Southwestern Medical Center###Presenter: – University of Texas Southwestern Medical Center
### 8:10 AM – 8:15 AM PT
1280 - Development of a Filtimator for Pediatric Image-Guided Radiation Therapy with Low Imaging DoseLocation: Room 8Presenter: – University of Florida Proton Therapy Institute
Soon Huh, PhD – University of Florida Proton Therapy Institute ### 1973027###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida Proton Therapy Institute###Presenter: – University of Florida Proton Therapy Institute
### 8:15 AM – 8:20 AM PT
1282 - Real Time 4D-Cone Beam CT via Single-Angle Projection with Dual Attention MechanismLocation: Room 8Presenter: – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Jun Dang, PhD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center ### 1973156###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center###Presenter: – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
### 8:20 AM – 8:25 AM PT
1284 - SEA-Net: Structure-Enhanced Attention Network for Limited-Angle CBCT Reconstruction of Clinical Projection DataLocation: Room 8Presenter: – University of Kansas Medical Center
Hao Gao, PhD – University of Kansas Medical Center ### 746653###Presenter###Disclosures: Employment: University of Kansas:Associate Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 8:25 AM – 8:30 AM PT
1286 - Rapid Unpaired CBCT-based Synthetic CT for CBCT-guided Adaptive RadiotherapyLocation: Room 8Presenter: – Emory University School of Medicine
Jacob Wynne, MD – Emory University School of Medicine ### 537584###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University School of Medicine###Presenter: – Emory University School of Medicine
### 8:30 AM – 8:35 AM PT
1288 - Liver Dome Gating Using kV Triggered Imaging Reduces Dosimetric Error Caused by Breath Hold Variability for Liver Stereotactic Body Radiation TherapyLocation: Room 8Presenter: – Cleveland Clinic Taussig Cancer Center
Bingqi Guo, PhD – Cleveland Clinic Taussig Cancer Center ### 747965###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 12:50 PM – 12:55 PM PT
1084 - Bacterial Composition and Diversity in the Cervical Tumor Microbiome are Closely Associated with HPV Genotype in a Large, International Patient CohortLocation: Room 7Presenter: – MD Anderson Cancer Center
Molly El Alam, MPH – MD Anderson Cancer Center ### 1972075###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:55 PM – 1:00 PM PT
1086 - Postoperative Radiotherapy to Abdominal and Pelvic Lymphatic Drainage Area for Stage III Epithelial Ovarian Cancer: A Sharp Tool to Prolong Disease-Free Survival TimeLocation: Room 7Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
Jing Shen, MD – Chinese Academy of Medical Sciences and Peking Union Medical College ### 1972076###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
### 1:00 PM – 1:05 PM PT
1088 - Genomic Characterization of Cervical Tumors Driven by Rare High-Risk HPV Subtypes Utilizing a Deep Learning FrameworkLocation: Room 7Presenter: – Washington University St. Louis
Michael Waters, MD, PhD – Washington University St. Louis ### 535929###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University St. Louis###Presenter: – Washington University St. Louis
### 1:10 PM – 1:15 PM PT
1092 - Machine-Learning Model of Pre-Treatment MRI Accurately Predicts Progression Following Cervical Cancer RadiotherapyLocation: Room 7Presenter: – George Washington University School of Medicine
Jeffrey Wang, BS – George Washington University School of Medicine ### 1972079###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###George Washington University School of Medicine###Presenter: – George Washington University School of Medicine
### 1:15 PM – 1:22 PM PT
1094 - The Prognostic Impact of Substantial Lymphovascular Space Invasion in Women with FIGO Stage I Uterine Endometrioid Carcinoma with Pathologically Negative Nodal EvaluationLocation: Room 7Presenter: – Henry Ford Hospital
Aseem Bhatnagar, MD – Henry Ford Hospital ### 1981332###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Henry Ford Hospital###Presenter: – Henry Ford Hospital
### 12:45 PM – 12:52 PM PT
224 - Intravoxel Incoherent Motion (IVIM) Magnetic Resonance Imaging (MRI) for Assessment of Treatment Response in Unresectable Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Location: Room 29Presenter: – MD Anderson Cancer Center
Lucas McCullum, BS – MD Anderson Cancer Center ### 2082187###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:55 PM – 1:02 PM PT
225 - Differential Response in Quantitative MRI Parameters Detected in Head and Neck Cancer Patients Treated with Concurrent Immunotherapy during Hypo-Fractionated MR-gRTLocation: Room 29Presenter: – Medical College of Wisconsin
Ryan Bonate, BS – Medical College of Wisconsin ### 1975173###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 1:05 PM – 1:12 PM PT
226 - Pattern Analysis of Daily Lesion Volume Trajectories for Early Prediction of Glioblastoma Progression During MR-Linac RadiotherapyLocation: Room 29Presenter: – University of Miami Sylvester Comprehensive Cancer Center
Kaylie Cullison, BS – University of Miami Sylvester Comprehensive Cancer Center ### 1972082###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Miami Sylvester Comprehensive Cancer Center###Presenter: – University of Miami Sylvester Comprehensive Cancer Center
### 1:15 PM – 1:22 PM PT
227 - Fraction Size, Total Dose and Respiratory Control Impact Local Control in Adrenal SBRTLocation: Room 29Presenter: – Tel Hashomer Hospital
Ory Haisraely, MD, MPH – Tel Hashomer Hospital ### 1975174###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tel Hashomer Hospital###Presenter: – Tel Hashomer Hospital
### 1:25 PM – 1:32 PM PT
228 - Tumor Voxel Dose-Response Matrix Prediction Using Deep LearningLocation: Room 29Presenter: – Corewell Health William Beaumont University Hospital
Shupeng Chen, PhD – Corewell Health William Beaumont University Hospital ### 1973070###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Corewell Health William Beaumont University Hospital###Presenter: – Corewell Health William Beaumont University Hospital
### 1:35 PM – 1:42 PM PT
229 - Image Derived Estimates of Fibrosis Using Ultrashort Echo Time MRI in Gynecologic CancerLocation: Room 29Presenter: – Johns Hopkins University School of Medicine
Khadija Sheikh, PhD, MS – Johns Hopkins University School of Medicine ### 536006###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University School of Medicine###Presenter: – Johns Hopkins University School of Medicine
### 1:45 PM – 1:52 PM PT
230 - Comprehensive Quality of Life Report from a Prospective Clinical Trial of 4DCT-Ventilation Functional Lung Avoidance Radiation TherapyLocation: Room 29Presenter: – MD Anderson Cancer Center at Cooper
Joseph Lombardo, DO – MD Anderson Cancer Center at Cooper ### 2027547###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center at Cooper###Presenter: – MD Anderson Cancer Center at Cooper
### 12:45 PM – 12:52 PM PT
218 - Management and Outcomes of Hodgkin Lymphoma Patients Who Achieve Partial Metabolic Response on PET Scans Post-ChemotherapyLocation: Room 1Presenter: – University of Toronto
Donna Liao, MD – University of Toronto ### 1972018###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Toronto###Presenter: – University of Toronto
### 12:55 PM – 1:02 PM PT
219 - Quality Analysis of Radiation Therapy for Hodgkin Lymphoma in the HD 16/17 Trials: A Final Report By the Reference Radiation Oncology Panel of the German Hodgkin Study GroupLocation: Room 1Presenter: – University Hospital of Muenster
Michael Oertel, MD – University Hospital of Muenster ### 1972019###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospital of Muenster###Presenter: – University Hospital of Muenster
### 1:05 PM – 1:12 PM PT
220 - Radiotherapy Utilization and Outcomes on a Contemporary Trial for Pediatric High-Risk Hodgkin Lymphoma StudyLocation: Room 1Presenter: – Mayo Clinic Florida
Bradford Hoppe, MD, FASTRO, MPH – Mayo Clinic Florida ### 535819###Presenter###Disclosures: Employment: Mayo Clinic:Professor of Radiation Oncology:Employee | Compensation: Merck: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Remuneration Other-End Date: Present | Ownership: none | Leadership: PTCOG:Secretary;NRG lymphoma working group:Co-Chair###Mayo Clinic Florida###Presenter: – Mayo Clinic Florida
### 1:15 PM – 1:22 PM PT
221 - Radiotherapy in Young, High-Risk Patients with Aggressive B-cell Lymphoma: Long-Term Results from the Open-Label, Randomized, Phase 3 R-MegaCHOEP TrialLocation: Room 1Presenter: – University Hospital of Muenster
Michael Oertel, MD – University Hospital of Muenster ### 1972019###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospital of Muenster###Presenter: – University Hospital of Muenster
### 1:25 PM – 1:32 PM PT
222 - Association of Overall Survival Benefit Profile of Radiotherapy with Progression-Free Survival after Chemotherapy for Diffuse Large B-Cell LymphomaLocation: Room 1Presenter: – Cancer Hospital Chinese Academy of Medical Sciences
Jingnan Wang, MD – Cancer Hospital Chinese Academy of Medical Sciences ### 1972020###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Hospital Chinese Academy of Medical Sciences###Presenter: – Cancer Hospital Chinese Academy of Medical Sciences
### 1:35 PM – 1:42 PM PT
223 - Radiation Therapy in the Management of Primary Gastric Diffuse Large B-Cell Lymphomas: Long-Term Outcomes of 82 PatientsLocation: Room 1Presenter: – Memorial Sloan Kettering Cancer Center
Beatrice Fregonese, MPH – Memorial Sloan Kettering Cancer Center ### 1972021###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 1:45 PM – 1:55 PM PT
DiscussantLocation: Room 1Discussant: – Stanford University
Richard Hoppe, MD, FASTRO – Stanford University ### 536142###Discussant###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Discussant: – Stanford University
### 12:50 PM – 12:55 PM PT
1096 - Impact of Consolidative Radiation on Overall and Progression Free Survival in Pediatric, Adolescent and Young Adult Metastatic SarcomaLocation: Room 8Presenter: – Johns Hopkins University
Leslie Chang, MD – Johns Hopkins University ### 1972059###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 12:55 PM – 1:00 PM PT
1098 - The Role of Whole Abdomen and Pelvis Radiation Therapy in Desmoplastic Small Round Cell TumorLocation: Room 8Presenter: – UNC Hospitals
Michael Young, MD – UNC Hospitals ### 1972060###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UNC Hospitals###Presenter: – UNC Hospitals
### 1:00 PM – 1:05 PM PT
1100 - Association between Radiation Dose and Local Failure in Recurrent High-Risk NeuroblastomaLocation: Room 8Presenter: – MD Anderson Cancer Center
Christopher Weil, MD, MS – MD Anderson Cancer Center ### 535876###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 1:05 PM – 1:10 PM PT
1102 - Proton Therapy Mediates Dose Reductions to Critical Brain Organs-at-Risk which are Associated with Better Cognition in Children with MedulloblastomaLocation: Room 8Presenter: – Juravinski Cancer Centre
Julianna Sienna, MD, MS – Juravinski Cancer Centre ### 747494###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Juravinski Cancer Centre###Presenter: – Juravinski Cancer Centre
### 1:10 PM – 1:15 PM PT
1104 - Memantine for Pediatric Patients Receiving Cranial Irradiation: A Pilot StudyLocation: Room 8Presenter: – Mayo Clinic Rochester
Elizabeth McKone, MD – Mayo Clinic Rochester ### 1972061###Presenter###Disclosures: Employment: Mayo Clinic Rochester:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Mayo Clinic Rochester###Presenter: – Mayo Clinic Rochester
### 1:15 PM – 1:20 PM PT
1106 - Pancreas: An Organ-at-Risk to Consider in Future Pediatric Abdominal RadiotherapyLocation: Room 8Presenter: – University College London
Sabrina Taylor, BS – University College London ### 1972062###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University College London###Presenter: – University College London
### 2:30 PM – 2:37 PM PT
231 - Involved Site Radiotherapy in HPV Positive Oropharyngeal Cancer: Patterns of Failure Analysis Across Prospective De-Escalation TrialsLocation: Room 1Presenter: – University of Chicago Medicine
Zaid Iftekaruddin, MD – University of Chicago Medicine ### 1975164###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Chicago Medicine###Presenter: – University of Chicago Medicine
### 2:40 PM – 2:47 PM PT
232 - A Phase II Trial Evaluating Rapid Mid-Treatment Nodal Shrinkage to Select for Adaptive Deescalation in p16+ Oropharyngeal Cancer Patients Undergoing Definitive ChemoradiationLocation: Room 1Presenter: – NYU Langone Medical Center
Joseph Kim, MD – NYU Langone Medical Center ### 537688###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU Langone Medical Center###Presenter: – NYU Langone Medical Center
### 2:50 PM – 2:57 PM PT
233 - Effectiveness of Cisplatin in P16+ Oropharyngeal Cancer According to Relative Risk for Cancer Events: Ancillary Analysis of RTOG 1016Location: Room 1Presenter: – University of California, San Diego
Loren Mell, MD, FASTRO – University of California, San Diego ### 516064###Presenter######University of California, San Diego###Presenter: – University of California, San Diego
### 2:50 PM – 2:57 PM PT
233 - Effectiveness of Cisplatin in P16+ Oropharyngeal Cancer According to Relative Risk for Cancer Events: Ancillary Analysis of RTOG 1016Location: Room 1Presenter: – University of North Carolina at Chapel Hill
Ryan Morse, MD – University of North Carolina at Chapel Hill ### 537838###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of North Carolina at Chapel Hill###Presenter: – University of North Carolina at Chapel Hill
### 3:00 PM – 3:07 PM PT
234 - Local Cost-Effectiveness of Nasopharyngeal Carcinoma Screening Strategies in Southern China: Secondary Analysis of the PRO-NPC-001 Cluster-Randomized TrialLocation: Room 1Presenter: – Cleveland Clinic Foundation
Jacob Miller, MD – Cleveland Clinic Foundation ### 537835###Presenter###Disclosures: Employment: Cleveland Clinic Foundation:Associate Staff:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Cleveland Clinic Foundation###Presenter: – Cleveland Clinic Foundation
### 3:10 PM – 3:17 PM PT
235 - Prospective Efficacy of Two Cycles Toripalimab Plus Induction Chemotherapy in T4 or N3 Locoregionally Advanced Nasopharyngeal Carcinoma: A Retrospective and Mechanistic StudyLocation: Room 1Presenter: – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Fengming Lan, MD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center ### 1975165###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center###Presenter: – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
### 3:20 PM – 3:30 PM PT
DiscussantLocation: Room 1Discussant: – Massachusetts General Hospital
Annie Chan, MD – Massachusetts General Hospital ### 525096###Discussant###Disclosures: Employment: MGH:physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Massachusetts General Hospital###Discussant: – Massachusetts General Hospital
### 2:35 PM – 2:40 PM PT
1108 - The Presence of Extensive Lymphovascular Invasion (LVI) is Associated with Higher Risk of Recurrence in Curatively Treated Breast Cancer PatientsLocation: Room 7Presenter: – Philadelphia College of Osteopathic Medicine
Olufela Koleoso, MS, BS – Philadelphia College of Osteopathic Medicine ### 1972088###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Philadelphia College of Osteopathic Medicine###Presenter: – Philadelphia College of Osteopathic Medicine
### 2:40 PM – 2:45 PM PT
1110 - 5-Year Results from a Prospective Phase II Trial of Ten-Fractions Hypofractionated Radiotherapy in Locally Advanced Breast CancerLocation: Room 7Presenter: – Regina Elena National Cancer Institute
Silvia Takanen, MD – Regina Elena National Cancer Institute ### 2057690###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Regina Elena National Cancer Institute###Presenter: – Regina Elena National Cancer Institute
### 2:45 PM – 2:50 PM PT
1112 - Addition of Metastasis-Directed Therapy to Standard of Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase II TrialLocation: Room 7Presenter: – MD Anderson Cancer Center
Jay Paul Reddy, MD, PhD – MD Anderson Cancer Center ### 746706###Presenter###Disclosures: Employment: MD Anderson Cancer Center:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 2:50 PM – 2:55 PM PT
1114 - First Results of the Primary Outcome of a Phase II Prospective Clinical Trial to Assess the Feasibility of Preoperative Radiation Boost in Breast Cancer PatientsLocation: Room 7Presenter: – Associates in Radiation Medicine-ARM Oncology
Zeinab Abou Yehia, MD – Associates in Radiation Medicine-ARM Oncology ### 537607###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Associates in Radiation Medicine-ARM Oncology###Presenter: – Associates in Radiation Medicine-ARM Oncology
### 2:55 PM – 3:00 PM PT
1116 - Single-Fraction Pre-Operative Stereotactic Radiosurgery for Early-Stage Breast Cancer: Pathological FindingsLocation: Room 7
Marco Trovo ### 2159044###Presenter#########Presenter:
### 3:00 PM – 3:05 PM PT
1118 - Factors Associated with Cardiac Radiation Dose Reduction Following Hypofractionated Radiation Therapy for Localized, Left-Sided Breast Cancer in a Large Statewide Quality ConsortiumLocation: Room 7Presenter: – University of Michigan
Daniel Herr, MD, PhD – University of Michigan ### 1972091###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 2:33 PM – 2:40 PM PT
243 - Results of a Phase I Trial of Dose Escalation for Preoperative Stereotactic Radiosurgery for Patients with Large Brain MetastasesLocation: Room 6 C/FPresenter: – Cleveland Clinic Taussig Cancer Center
Kailin Yang, MD, PhD – Cleveland Clinic Taussig Cancer Center ### 746583###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 2:43 PM – 2:50 PM PT
244 - Radiotherapy for Metastatic Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 TrialLocation: Room 6 C/FPresenter: – University of Luebeck
Dirk Rades, MD, FASTRO – University of Luebeck ### 1974897###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Luebeck###Presenter: – University of Luebeck
### 2:53 PM – 3:00 PM PT
245 - Results of a Multi-institutional Randomized Phase 3 Trial of Parotid-Sparing Whole Brain RadiotherapyLocation: Room 6 C/FPresenter: – University of Cincinnati
Kyle Wang, MD – University of Cincinnati ### 524693###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Cincinnati###Presenter: – University of Cincinnati
### 3:03 PM – 3:10 PM PT
246 - Evidence-Based Multivariate Normal Tissue Complication Probability (NTCP) Study of Domain-Specific Cognitive Decline after Partial Brain RTLocation: Room 6 C/FPresenter: – UCSD Radiation Medicine and Applied Sciences
Austin Hopper, MD – UCSD Radiation Medicine and Applied Sciences ### 747811###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSD Radiation Medicine and Applied Sciences###Presenter: – UCSD Radiation Medicine and Applied Sciences
### 3:13 PM – 3:20 PM PT
247 - Genomic Predictors of Leptomeningeal Disease Development among Patients with Brain MetastasesLocation: Room 6 C/FPresenter: – Harvard Radiation Oncology Program
Nayan Lamba, MD – Harvard Radiation Oncology Program ### 537685###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 3:23 PM – 3:28 PM PT
1262 - Stereotactic Radiotherapy or Whole Brain Radiotherapy Combined with Pyrotinib and Capecitabine in HER2-Positive Advanced Breast Cancer Patients with Brain Metastases (BROPTIMA): A Prospective, Phase ILocation: Room 6 C/FPresenter: – Fudan University Shanghai Cancer Center
Wei Shi, MD, PhD – Fudan University Shanghai Cancer Center ### 1972364###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fudan University Shanghai Cancer Center###Presenter: – Fudan University Shanghai Cancer Center
### 3:28 PM – 3:38 PM PT
DiscussantLocation: Room 6 C/FDiscussant: – Levine Cancer Institute
Stuart Burri, MD – Levine Cancer Institute ### 535892###Discussant###Disclosures: Employment: Southeast Radiation Oncology Group:President and Partner:Partner | Compensation: Novocure: Other, Travel Expenses, Compensation Payment-End Date: present | Ownership: Southeast Radiation Oncology Group:Partnership;Radiation Oncology Centers of the Carolinas:Ownership Equity;Charlotte Physics Holding:Ownership Equity;FUSE Oncology Holding:Ownership Equity;Oncology Practice Solutions:Ownership Equity | Leadership: Atrium Health - Levine Cancer Institute:Chairman of Radiation Oncology###Levine Cancer Institute###Discussant: – Levine Cancer Institute
### 2:30 PM – 2:37 PM PT
236 - Neoantigen Cancer Vaccine Improves the Therapeutic Efficacy of Radiotherapy in Immunologically Cold Microsatellite-Stable Colorectal CancerLocation: Room 2Presenter: – China Medical University Hospital
K. S. Clifford Chao, MD – China Medical University Hospital ### 2010449###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###China Medical University Hospital###Presenter: – China Medical University Hospital
### 2:40 PM – 2:47 PM PT
237 - Non-Redundant Mechanisms of Immune Resistance to Radiotherapy Converge on Innate ImmunityLocation: Room 2Presenter: – Cedars-Sinai Medical Center
Anthony Nguyen, MD, PhD – Cedars-Sinai Medical Center ### 747824###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 2:50 PM – 2:57 PM PT
238 - The Effect of PARP Inhibitor Radiosensitization on the mRNA Translational Regulation of T Cell ChemokinesLocation: Room 2Presenter: – Princess Margaret Cancer Centre
Benjamin Lok, MD – Princess Margaret Cancer Centre ### 524997###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Centre###Presenter: – Princess Margaret Cancer Centre
### 2:50 PM – 2:57 PM PT
238 - The Effect of PARP Inhibitor Radiosensitization on the mRNA Translational Regulation of T Cell ChemokinesPresenter: – University Health Network
Xiaozhuo Ran, PhD – University Health Network ### 1972003###Presenter######University Health Network###Presenter: – University Health Network
### 3:00 PM – 3:07 PM PT
239 - Radiotherapy Shows Synergistic Anti-Tumor Efficacy with Treg Depletion by Reprogramming the Immune-Excluded Tumor MicroenvironmentLocation: Room 2Presenter: – Varian Medical Systems, A Siemens Healthineers Company
Sophia Pfister, PhD – Varian Medical Systems, A Siemens Healthineers Company ### 2029569###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Varian Medical Systems, A Siemens Healthineers Company###Presenter: – Varian Medical Systems, A Siemens Healthineers Company
### 3:10 PM – 3:17 PM PT
240 - Blocking ILT4 Overcomes Radio-Immunotherapy Treatment Resistance by Reversing HFRT Induced CXCL1-CXCR2 Axis Activation and Tumor-Associated Macrophages ImmunosuppressionLocation: Room 2
Xiaozheng Chen, PhD ### 1972005###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:30 PM – 3:40 PM PT
DiscussantLocation: Room 2Discussant: – University of Wisconsin Hospitals and Clinics
Zachary Morris, MD, PhD – University of Wisconsin Hospitals and Clinics ### 524492###Discussant###Disclosures: Employment: University of Wisconsin-Madison:Associate Professor:Employee | Compensation: Archeus Technologies: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: Present ;Seneca Therapeutics: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: Present | Ownership: Wisconsin Alumni Research Foundation:Copyright;Archeus Technologies:Stock Options;Seneca Therapeutics:Stock Options | Leadership: none###University of Wisconsin Hospitals and Clinics###Discussant: – University of Wisconsin Hospitals and Clinics
### 2:30 PM – 3:45 PM PT
2972 - Diagnostic Performance of 18F-rhPSMA-7.3 PET in Men with Newly Diagnosed High-Risk Prostate Cancer and Negative Conventional ImagingLocation: Hall B1
Gary Ulaner, MD, PhD ### 1972660###Presenter#########Presenter:
### 2:30 PM – 2:40 PM PT
LBA 08 - Acute Toxicity and Efficiency Outcomes in the DARTBOARD Randomized Trial of Daily Adaptive Radiotherapy for Head and Neck Squamous Cell CarcinomaLocation: Room 6 BPresenter: – University of Texas Southwestern Medical Center
David Sher, MD, MPH – University of Texas Southwestern Medical Center ### 516014###Presenter###Disclosures: Employment: University of Texas Southwestern Medical Center:Professor:Employee | Compensation: Varian Medical Center: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 03/01/2024 | Ownership: none | Leadership: none###University of Texas Southwestern Medical Center###Presenter: – University of Texas Southwestern Medical Center
### 2:40 PM – 2:50 PM PT
LBA 09 - Stereotactic Ablative Body Radiotherapy (SABR) for Oligoprogressive ER-Positive Breast Cancer (AVATAR): A Phase II Prospective Multicenter TrialLocation: Room 6 BPresenter: – Peter MacCallum Cancer Centre
Steven David, MD, MBBS – Peter MacCallum Cancer Centre ### 2105489###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peter MacCallum Cancer Centre###Presenter: – Peter MacCallum Cancer Centre
### 2:50 PM – 3:00 PM PT
LBA 10 - Partial Breast Radiotherapy for Women with Early Breast Cancer: 10-Year Outcomes from IMPORT LOW (CRUK/06/003)Location: Room 6 BPresenter: – Royal Marsden NHS Foundation Trust
Anna Kirby, MD – Royal Marsden NHS Foundation Trust ### 1974947###Presenter###Disclosures: Employment: Royal Marsden/ Institute of Cancer Research:Consultant Oncologist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: European Society of Radiotherapy and Oncology:President 2022-24###Royal Marsden NHS Foundation Trust###Presenter: – Royal Marsden NHS Foundation Trust
### 3:00 PM – 3:10 PM PT
LBA 11 - Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast CancerLocation: Room 6 BPresenter: – University of Texas Southwestern Medical Center
Asal Rahimi, MD, MS – University of Texas Southwestern Medical Center ### 524517###Presenter###Disclosures: Employment: University Texas Southwestern Medical School:Associate Professor:Employee | Compensation: Accuray: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Education Meeting Faculty, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria, Travel Expenses-End Date: present ;GE Health: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 2022 ;Hologic: Consultant, Education Meeting Faculty, Honoraria, Compensation Payment-End Date: 2022 | Ownership: none | Leadership: NCCN:Breast Cancer Risk Reduction Panel###University of Texas Southwestern Medical Center###Presenter: – University of Texas Southwestern Medical Center
### 3:10 PM – 3:20 PM PT
LBA 12 - Stereotactic Radiosurgery for 1-10 Brain Metastases avoids Whole-Brain Radiotherapy - Results of the CYBER-SPACE Randomized Phase 2 TrialLocation: Room 6 BPresenter: – University Medical Center Gottingen (UMG)
Rami El Shafie, MD – University Medical Center Gottingen (UMG) ### 2105490###Presenter######University Medical Center Gottingen (UMG)###Presenter: – University Medical Center Gottingen (UMG)
### 3:20 PM – 3:30 PM PT
LBA 13 - Hypofractionated Stereotactic Radiotherapy (HFSRT) of the Resection Cavity versus Whole-Brain Radiotherapy (WBRT) following Brain Metastasis Resection - Results of the ESTRON Randomized Phase 2 TrialLocation: Room 6 BPresenter: – University Medical Center Gottingen (UMG)
Rami El Shafie, MD – University Medical Center Gottingen (UMG) ### 2105490###Presenter######University Medical Center Gottingen (UMG)###Presenter: – University Medical Center Gottingen (UMG)
### 3:30 PM – 3:40 PM PT
LBA 14 - Diagnostic CT-Enabled Radiation Therapy (DART): Results of a Randomized Trial for Palliative Radiation TherapyLocation: Room 6 BPresenter: – London Regional Cancer Program
Melissa O'Neil, MRT(T) – London Regional Cancer Program ### 2082172###Presenter###Disclosures: Employment: London Regional Cancer Program:Clinical Specialist Radiation Therapist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###London Regional Cancer Program###Presenter: – London Regional Cancer Program
### 4:00 PM – 4:07 PM PT
248 - Outcomes Following Radiation Therapy (RT) for Very Young Age CNS Embryonal Tumors on COG ACNS0334 According to Molecular-Confirmed DiagnosisLocation: Room 2Presenter: – SUNY Upstate Radiation Oncology
Katherine Schumacher, MD – SUNY Upstate Radiation Oncology ### 1972008###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###SUNY Upstate Radiation Oncology###Presenter: – SUNY Upstate Radiation Oncology
### 4:10 PM – 4:17 PM PT
249 - Long Term Clinical Outcome and Quality of Life of Children, Adolescents and Young Adults Treated with Pencil Beam Scanning Proton Therapy for RhabdomyosarcomaLocation: Room 2Presenter: – Paul Scherrer Institute
Dominic Leiser, MD – Paul Scherrer Institute ### 1972009###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Paul Scherrer Institute###Presenter: – Paul Scherrer Institute
### 4:20 PM – 4:27 PM PT
250 - High-Dose-Rate Brachytherapy for Vaginal Rhabdomyosarcoma (RMS): Lessons Learned at a Single InstitutionLocation: Room 2Presenter: – Memorial Sloan Kettering Cancer Center
Kaitlyn Lapen, MD – Memorial Sloan Kettering Cancer Center ### 747748###Presenter###Disclosures: Employment: Memorial Sloan Kettering Cancer Center:Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 4:30 PM – 4:37 PM PT
251 - Dose-Effect of Proton and Photon Craniospinal Irradiation on Vertebral Growth in Pediatric Patients with MedulloblastomaLocation: Room 2Presenter: – St. Jude Children's Research Hospital
Carol Oliveira, MD, PhD – St. Jude Children's Research Hospital ### 747246###Presenter######St. Jude Children's Research Hospital###Presenter: – St. Jude Children's Research Hospital
### 4:40 PM – 4:47 PM PT
252 - Intraoperative Radiation Therapy for Pediatric Patients: A 25 Year ExperienceLocation: Room 2Presenter: – University of Miami Miller School of Medicine
Brianna Conte, BS – University of Miami Miller School of Medicine ### 1972010###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Miami Miller School of Medicine###Presenter: – University of Miami Miller School of Medicine
### 4:50 PM – 5:00 PM PT
DiscussantLocation: Room 2Discussant: – Stanford University
Susan Hiniker, MD – Stanford University ### 525198###Discussant###Disclosures: Employment: Stanford University:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Stanford University###Discussant: – Stanford University
### 4:05 PM – 4:10 PM PT
1132 - Proton Single-Energy Bragg-Peak FLASH Using Clinical Systems Can Achieve IMPT-Equivalent Plan Quality for Breast and Prostate CancersLocation: Room 7Presenter: – Hofstra University
Tyler Kaulfers, BS – Hofstra University ### 2123548###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hofstra University###Presenter: – Hofstra University
### 4:10 PM – 4:15 PM PT
1134 - Initial Experience with the Commercial Electron FLASH Research ExtensionLocation: Room 7Presenter: – University of Nebraska Medical Center
Kyle Gallagher, PhD – University of Nebraska Medical Center ### 1972050###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Nebraska Medical Center###Presenter: – University of Nebraska Medical Center
### 4:15 PM – 4:20 PM PT
1136 - 3D Dosimetry for Electron Flash Radiotherapy: Assessment of Radiochromic Dosimeter Phantoms with Optical CT Scanning as a 3D Dosimetry SystemLocation: Room 7Presenter: – Columbia University Irving Medical Center
Carl Elliston, MS, DABR – Columbia University Irving Medical Center ### 1972051###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Columbia University Irving Medical Center###Presenter: – Columbia University Irving Medical Center
### 4:20 PM – 4:25 PM PT
1138 - Proton LET Optimization Via Iterative Convex Relaxation MethodLocation: Room 7Presenter: – University of Kansas Medical Center
Wangyao Li, PhD – University of Kansas Medical Center ### 1972052###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 4:25 PM – 4:30 PM PT
1140 - Clinical Characterization of a Novel Robotic IORT UnitLocation: Room 7Presenter: – Stanford Advanced Medicine Center
Thomas Niedermayer, PhD – Stanford Advanced Medicine Center ### 1972053###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Advanced Medicine Center###Presenter: – Stanford Advanced Medicine Center
### 4:30 PM – 4:35 PM PT
1142 - Efficacy of Curvilinear Needle Implantation for Prostate HDR BrachytherapyLocation: Room 7Presenter: – University of Florida
Rihan Podder, BS – University of Florida ### 1972054###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida###Presenter: – University of Florida
### 4:05 PM – 4:10 PM PT
1120 - Sema3C Signaling is an Alternative Activator of the Canonical WNT Pathway in GlioblastomaLocation: Room 8Presenter: – Cleveland Clinic Taussig Cancer Center
Jennifer Yu, MD, PhD – Cleveland Clinic Taussig Cancer Center ### 524586###Presenter###Disclosures: Employment: Cleveland Clinic:Staff:Employee | Compensation: NIH: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Cleveland Clinic: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Case Comprehensive Cancer Center: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present | Ownership: Abbvie:Stock;Medtronics:Stock | Leadership: International Journal of Hyperthermia:Associate Editor;Molecular Carcinogenesis:Associate Editor;Frontiers in Oncology:Associate Editor###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 4:10 PM – 4:15 PM PT
1122 - Tumor Resistance to Fractionated Radiotherapy in Obese MiceLocation: Room 8Presenter: – University of California, Davis
Logan Vick, BA – University of California, Davis ### 1975186###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, Davis###Presenter: – University of California, Davis
### 4:15 PM – 4:20 PM PT
1124 - IKBKE Promotes Radioresistance of Glioblastoma through AKT/FOXO3a PathwayLocation: Room 8
Jie Lu, PhD ### 1975187###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:20 PM – 4:25 PM PT
1126 - RAP80 Phase Separation at DNA Double-Strand Break Promotes BRCA1 Recruitment and Tumor Radio-ResistanceLocation: Room 8Presenter: – Sixth Affiliated Hospital, Sun Yat-sen University
Xinjuan Fan, MD, PhD – Sixth Affiliated Hospital, Sun Yat-sen University ### 1975188###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sixth Affiliated Hospital, Sun Yat-sen University###Presenter: – Sixth Affiliated Hospital, Sun Yat-sen University
### 4:25 PM – 4:30 PM PT
1128 - Mitotic Errors Increase Radiation Sensitivity in Multiple Cancer Cell Types and in Laryngeal Cancer PatientsLocation: Room 8Presenter: – University of Wisconsin
Pippa Cosper, MD, PhD – University of Wisconsin ### 525164###Presenter###Disclosures: Employment: University of Wisconsin-Madison:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Wisconsin###Presenter: – University of Wisconsin
### 4:30 PM – 4:35 PM PT
1130 - Novel Role of Glycogen Synthase Kinase-3ß in Determining Cancer Cell Response to Genotoxic Stress through Regulation of 53BP1 FunctionLocation: Room 8Presenter: – Duke University
Scarlett Acklin, MD – Duke University ### 746682###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University###Presenter: – Duke University
### 4:05 PM – 4:10 PM PT
1144 - Leveraging a Real-Time Machine Learning Platform to Personalize Quality Assurance at a Large Multi-Site Oncology PracticeLocation: Room 4Presenter: – Oncora Medical LLC
William Lindsay, MD, PhD – Oncora Medical LLC ### 1972092###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Oncora Medical LLC###Presenter: – Oncora Medical LLC
### 4:10 PM – 4:15 PM PT
1146 - Natural Language Processing Identification of Symptoms in Emergency Department Visits in Patients Receiving RadiationLocation: Room 4Presenter: – University of California San Francisco
Alexander Qian, MD – University of California San Francisco ### 2074982###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 4:15 PM – 4:20 PM PT
1148 - Clinical Usability-Oriented Automatic Contour Quality Evaluation for Deep Learning Auto-SegmentationLocation: Room 4Presenter: – Medical College of Wisconsin
Ying Zhang, PhD – Medical College of Wisconsin ### 536015###Presenter###Disclosures: Employment: Medical College of Wisconsin:Clinical Medical Physicist/Instructor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 4:20 PM – 4:25 PM PT
1150 - Mitigation of IMRT/SBRT Treatment Planning Errors on the First Biology-Guided Radiotherapy System Using FMEA within Six Sigma FrameworkLocation: Room 4Presenter: – University of Alabama at Birmingham
Eric Simiele, PhD – University of Alabama at Birmingham ### 1972094###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Alabama at Birmingham###Presenter: – University of Alabama at Birmingham
### 4:25 PM – 4:30 PM PT
1152 - Quality and Safety Considerations in Image Guided Radiation Therapy: An ASTRO Safety White Paper UpdateLocation: Room 4
Terence Sio, MD, MS – Mayo Clinic ### 535761###Presenter###Disclosures: Employment: Mayo Clinic Arizona:Radiation Oncologist:Employee | Compensation: Catalyst Pharmaceuticals, Inc.: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 12/31/2022 ;Galera Therapeutics: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 12/31/2022 ;Novocure, Inc.: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Speaker's Bureau, Honoraria, Travel Expenses-End Date: 12/31/2022 | Ownership: none | Leadership: none###Mayo Clinic###Presenter: – Mayo Clinic
### 4:30 PM – 4:35 PM PT
1154 - Assessing the Sustainability of Initiatives Aimed to Enhance Patient Safety Culture: A > 10-year Experience with Multifaceted InterventionsLocation: Room 4Presenter: – UNC School of Medicine
Ashley Weiner, MD, PhD – UNC School of Medicine ### 1972710###Presenter###Disclosures: Employment: University of North Carolina:Assistant Professor:Employee | Compensation: EmpNia: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: present ;Varian: Consultant-End Date: present | Ownership: none | Leadership: none###UNC School of Medicine###Presenter: – UNC School of Medicine
### 4:05 PM – 4:10 PM PT
1156 - Meta-Analysis of Five Fraction Preoperative Radiotherapy for Soft Tissue SarcomaLocation: Room 5Presenter: – Cleveland Clinic Foundation
Zachary Mayo, MD – Cleveland Clinic Foundation ### 1972095###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Foundation###Presenter: – Cleveland Clinic Foundation
### 4:10 PM – 4:15 PM PT
1158 - Initial Results of a Phase II Trial of Hypofractionated Radiation Therapy for Inoperable Soft Tissue SarcomaLocation: Room 5Presenter: – University of Wisconsin Hospitals and Clinics
Bradley Eckelmann, MD, PhD – University of Wisconsin Hospitals and Clinics ### 1972096###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin Hospitals and Clinics###Presenter: – University of Wisconsin Hospitals and Clinics
### 4:15 PM – 4:20 PM PT
1160 - Hypofractionated Accelerated Radiation Dose-Painting (HARD) Improves Local Control in Unresected Soft-Tissue SarcomaLocation: Room 5Presenter: – Moffitt Cancer Center
John Michael Bryant, MD – Moffitt Cancer Center ### 1972097###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Moffitt Cancer Center###Presenter: – Moffitt Cancer Center
### 4:20 PM – 4:25 PM PT
1162 - Pre-Operative Radiotherapy in STS: Does Downsizing Matter?Location: Room 5Presenter: – Medical College of Wisconsin Froedtert Hospital
Paulina Gutkin, BS – Medical College of Wisconsin Froedtert Hospital ### 747121###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin Froedtert Hospital###Presenter: – Medical College of Wisconsin Froedtert Hospital
### 4:25 PM – 4:30 PM PT
1164 - Dawn of Staging for Head and Neck Soft Tissue Sarcoma: Validation of the Novel 8th Edition AJCC T Classification and Proposed Stage GroupingsLocation: Room 5Presenter: – Princess Margaret Cancer Center, University Health Network
Rohan Salunkhe, MD, MBBS – Princess Margaret Cancer Center, University Health Network ### 747578###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Center, University Health Network###Presenter: – Princess Margaret Cancer Center, University Health Network
### 4:30 PM – 4:35 PM PT
1166 - Outcomes for Patients with Head and Neck Sarcoma Treated Curatively with Radiation Therapy and SurgeryLocation: Room 5Presenter: – MD Anderson Cancer Center
Alison Yoder, MD, MPH – MD Anderson Cancer Center ### 535882###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 4:35 PM – 4:40 PM PT
1168 - Patterns of local recurrence and risk of skin recurrence in soft tissue sarcomas after surgical resection.Location: Room 5Presenter: – Stanford University
Agnes Ewongwo, MD – Stanford University ### 1972098###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 4:00 PM – 5:00 PM PT
Hypofractionated Radiotherapy for Hematological Malignancies during COVID-19 Pandemic and BeyondPresenter: – Amala Institute of Medical Sciences, Thrissur
Febin Antony, MD, MBBS – Amala Institute of Medical Sciences, Thrissur ### 1972745###Presenter######Amala Institute of Medical Sciences, Thrissur###Presenter: – Amala Institute of Medical Sciences, Thrissur
### 4:00 PM – 5:00 PM PT
2992 - Development of Population-Based Pediatric Computational Phantoms for Radiotherapy ApplicationsLocation: Hall B1Presenter: – University College London
Reem Ahmad, PhD – University College London ### 1972760###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University College London###Presenter: – University College London
### 5:15 PM – 5:22 PM PT
259 - FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Location: Room 6 BPresenter: – Brigham and Women's Hospital/Dana-Farber
Paul Nguyen, MD, FASTRO – Brigham and Women's Hospital/Dana-Farber ### 525077###Presenter###Disclosures: Employment: Brigham and Womens:Physician:Employee | Compensation: Blue Earth: Consultant-End Date: 12/16/21 ;Janssen: Consultant, Grant Research Funding, Honoraria-End Date: Present ;Boston Scientific: Consultant, Honoraria-End Date: Present ;Bayer: Consultant, Honoraria-End Date: 11/1/22 ;Novartis: Consultant, Honoraria-End Date: 12/5/22 ;Nanocan: Consultant, Honoraria-End Date: Present ;Astellas: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present | Ownership: Nanocan:Ownership Equity;Telerad Oncology:Ownership Equity | Leadership: none###Brigham and Women's Hospital/Dana-Farber###Presenter: – Brigham and Women's Hospital/Dana-Farber
### 5:25 PM – 5:32 PM PT
260 - Final Results from a Prospective Randomized Pilot Trial of Stereotactic Body Radiation Therapy vs. Radiofrequency Ablation for the Management of Small Renal Masses (RADSTER)Location: Room 6 BPresenter: – Juravinski Cancer Centre
Anand Swaminath, MD – Juravinski Cancer Centre ### 535861###Presenter###Disclosures: Employment: Anand Swaminath Medicine Professional Corporation:Radiation Oncologist:Employee | Compensation: Astrazeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Education Meeting Faculty, Honoraria-End Date: present ;Eisai: Education Meeting Faculty, Honoraria-End Date: Mar 2021 ;Roche: Research Grants, Research Funding, Research Salary Support,Research Role Description Topic-End Date: present ;Bristol-Myers Squibb: Education Meeting Faculty, Honoraria-End Date: Nov 2022 | Ownership: none | Leadership: none###Juravinski Cancer Centre###Presenter: – Juravinski Cancer Centre
### 5:35 PM – 5:42 PM PT
261 - Impact of Testosterone Recovery on Clinical Outcomes of Patients Treated with Salvage Radiotherapy and Androgen Suppression: A Secondary Analysis of the NRG/RTOG 0534 Spport Phase 3 TrialLocation: Room 6 BPresenter: – University of Miami - Sylvester Cancer Center
Alan Dal Pra, MD – University of Miami - Sylvester Cancer Center ### 536090###Presenter###Disclosures: Employment: University of Miami:Associate Professor and Medical Director:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Miami - Sylvester Cancer Center###Presenter: – University of Miami - Sylvester Cancer Center
### 5:45 PM – 5:52 PM PT
262 - Post-Prostatectomy Risk Stratification of Biochemical Recurrence Using Transfer Learning-Based Multi-Modal Artificial IntelligenceLocation: Room 6 BPresenter: – Case Western Reserve University
Atallah Baydoun, MD, PhD – Case Western Reserve University ### 1972007###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Case Western Reserve University###Presenter: – Case Western Reserve University
### 5:55 PM – 6:02 PM PT
263 - 5-Year Renal Function Outcomes after SABR for Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium of the Kidney (IROCK)Location: Room 6 BPresenter: – London Health Sciences Centre
Vivian Tan, MD – London Health Sciences Centre ### 1972041###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###London Health Sciences Centre###Presenter: – London Health Sciences Centre
### 6:05 PM – 6:15 PM PT
DiscussantLocation: Room 6 BDiscussant: – Medical College of Wisconsin (MCW)
William Hall, MD – Medical College of Wisconsin (MCW) ### 525191###Discussant###Disclosures: Employment: Medical College of Wisconsin:Associate Professor:Employee | Compensation: Aktis Oncology: Consultant, Compensation Payment-End Date: Present ;Elekta AB, Stockholm, Sweden: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Travel Expenses-End Date: Present | Ownership: none | Leadership: none###Medical College of Wisconsin (MCW)###Discussant: – Medical College of Wisconsin (MCW)
### 5:15 PM – 5:22 PM PT
253 - Impact of War on Radiotherapy in UkraineLocation: Room 2Presenter: – Stanford Cancer Institute Palo Alto
Yuliia Lozko, MD – Stanford Cancer Institute Palo Alto ### 1972032###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Cancer Institute Palo Alto###Presenter: – Stanford Cancer Institute Palo Alto
### 5:25 PM – 5:32 PM PT
254 - Radiotherapy Resources in Latin America and the Caribbean: An International Atomic Energy Agency Analysis of Current and Projected NeedsLocation: Room 2Presenter: – Indiana University
May Elbanna, MD, PhD – Indiana University ### 1971540###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Indiana University###Presenter: – Indiana University
### 5:35 PM – 5:42 PM PT
255 - Timely Access to Oncological Treatment in Brazil: Analysis of the 60-Law Compliance in a State DatabaseLocation: Room 2Presenter: – Johns Hopkins School of Public Health
CecÃlia de Sousa, MD – Johns Hopkins School of Public Health ### 1972033###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins School of Public Health###Presenter: – Johns Hopkins School of Public Health
### 5:45 PM – 5:52 PM PT
256 - Impact of AI-Based Auto-Segmentation on Radiotherapy Processes in Low and Middle-Income CountriesLocation: Room 2Presenter: – Uganda Cancer Institute
Solomon Kibudde, MBBS – Uganda Cancer Institute ### 1972034###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Uganda Cancer Institute###Presenter: – Uganda Cancer Institute
### 5:55 PM – 6:02 PM PT
257 - SCCAg as a Biomarker of Advanced Stage and OS in Limited Resource Setting for Cervical CancerLocation: Room 2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Rohini Bhatia, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 538056###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 6:05 PM – 6:12 PM PT
258 - Cobalt Compensator-Based IMRT for Gynecologic Cancer Treatment in Low- and Middle-Income Countries: Equivalence to LINAC-Based IMRTLocation: Room 2Presenter: – University of Washington
Peter Zaki, MD – University of Washington ### 1972035###Presenter###Disclosures: Employment: University of Washington:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 5:20 PM – 5:25 PM PT
1194 - Influence of Radiation Fractionation on Immune Repertoire Diversity in Solid Tumor PatientsLocation: Room 8Presenter: – University of Pittsburgh Medical Center
Susannah Ellsworth, MD – University of Pittsburgh Medical Center ### 525331###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pittsburgh Medical Center###Presenter: – University of Pittsburgh Medical Center
### 5:25 PM – 5:30 PM PT
1196 - Single-Cell and Spatial Transcriptomics Revealing the Role of IDO1 in HPV+ Cervical Cancer Tumor Immune Microenvironment and Its Implications in Radiotherapy and ImmunotherapyLocation: Room 8Presenter: – The University of Hong Kong
Zheng Danyang, MD, PhD, MS – The University of Hong Kong ### 1972071###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The University of Hong Kong###Presenter: – The University of Hong Kong
### 5:35 PM – 5:40 PM PT
1200 - Characterization of Peripheral T-Cell Dynamics in the Patients with Bone Metastasis from Breast Cancer Following Stereotactic Body RadiotherapyLocation: Room 8Presenter: – Seoul National University
In Ah Kim, MD, PhD – Seoul National University ### 535890###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University###Presenter: – Seoul National University
### 5:40 PM – 5:45 PM PT
1202 - PARP Inhibitor Plus Radiotherapy Reshapes IDH1 Mutation Tumor Immune Suppression Microenvironment Potentiating the Efficiency of Immune Checkpoint InhibitorLocation: Room 8Presenter: – Shandong Cancer Hospital and Institute
Xiaoyu Hu, MD, PhD – Shandong Cancer Hospital and Institute ### 1972073###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 5:45 PM – 5:50 PM PT
1204 - Loss of MAPKAPK2 Enhances cGAS-STING-IFNß1 Pathway Activation in Head and Neck Squamous Cell CarcinomaLocation: Room 8
Deri Morgan, PhD – KUMC ### 1972074###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###KUMC###Presenter: – KUMC
### 5:20 PM – 5:25 PM PT
1182 - Automatic Prediction of Metastasis-Free Survival (MFS) Using Prostate-Specific Membrane Antigen (PSMA) PET for Oligometastatic Castration-Sensitive Prostate Cancer (omCSPC)Location: Room 7Presenter: – University of Maryland Central Maryland Radiation Oncology
Yufeng Cao, PhD – University of Maryland Central Maryland Radiation Oncology ### 1972080###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland Central Maryland Radiation Oncology###Presenter: – University of Maryland Central Maryland Radiation Oncology
### 5:25 PM – 5:30 PM PT
1184 - A Dosimetric Study Indicates the Spinal Cord Irradiation Contributes to Acute Hematologic Toxicities in Non-Small Cell Lung Cancer Patients Receiving Radiotherapy Combined with ImmunotherapyLocation: Room 7Presenter: – Shandong Cancer Hospital and Institute
Jiachun Ma – Shandong Cancer Hospital and Institute ### 1972081###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 5:30 PM – 5:35 PM PT
1186 - Novel Functional Radiomics for Prediction of Cardiac PET Avidity in Lung Cancer RadiotherapyLocation: Room 7Presenter: – Thomas Jefferson University
Wookjin Choi, PhD – Thomas Jefferson University ### 525117###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 5:35 PM – 5:40 PM PT
1188 - Prognostic Value of Weekly Delta-Radiomics during MR-Linac Radiotherapy of GlioblastomaLocation: Room 7Presenter: – University of Miami Sylvester Comprehensive Cancer Center
Kaylie Cullison, BS – University of Miami Sylvester Comprehensive Cancer Center ### 1972082###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Miami Sylvester Comprehensive Cancer Center###Presenter: – University of Miami Sylvester Comprehensive Cancer Center
### 5:40 PM – 5:45 PM PT
1190 - A Radiogenomic Machine Learning Model for Glioblastoma Post-Resection Overall Survival Group PredictionLocation: Room 7Presenter: – Duke University
Lana Wang, MS – Duke University ### 1972083###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University###Presenter: – Duke University
### 5:45 PM – 5:50 PM PT
1192 - Prediction of Anatomical Presentation during Radiotherapy of Nasopharyngeal Carcinoma Using GAN-LSTM for Plan Adaption DecisionLocation: Room 7Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
Bining Yang, PhD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy ### 1972084###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy###Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
### 5:20 PM – 5:25 PM PT
1170 - Definitive Chemoradiation Treatment Response Evaluation Using NI-RADS and ctHPVDNA for HPV-Associated Oropharyngeal Squamous Cell CarcinomaLocation: Room 4Presenter: – University of North Carolina at Chapel Hill
Ryan Morse, MD – University of North Carolina at Chapel Hill ### 537838###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of North Carolina at Chapel Hill###Presenter: – University of North Carolina at Chapel Hill
### 5:25 PM – 5:30 PM PT
1172 - The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer in NRG/RTOG 1016Location: Room 4Presenter: – UCLA Radiation Oncology
Joanne Weidhaas, MD, PhD – UCLA Radiation Oncology ### 524487###Presenter###Disclosures: Employment: UCLA:Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: MiraDx:Copyright, Ownership Equity | Leadership: MiraKind:Founder, chairperson###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 5:30 PM – 5:35 PM PT
1174 - Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx CancerLocation: Room 4Presenter: – University of Chicago
Daniel Huang, MD – University of Chicago ### 1972085###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Chicago###Presenter: – University of Chicago
### 5:35 PM – 5:40 PM PT
1176 - A Pilot, First in Human Study of Autologous IFN-Gamma Stimulated Mesenchymal Stromal Cells for Treatment of Radiation-Induced XerostomiaLocation: Room 4Presenter: – University of Wisconsin
Grace Blitzer, MD – University of Wisconsin ### 746773###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin###Presenter: – University of Wisconsin
### 5:40 PM – 5:45 PM PT
1178 - Delta-Radiomics Guides Adaptive De-Intensification after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma in the IMRT EraLocation: Room 4Presenter: – Sun Yat-Sen University Cancer Center
Shun-Xin Wang, MD – Sun Yat-Sen University Cancer Center ### 1972086###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 5:45 PM – 5:50 PM PT
1180 - Risk-Stratification using the 40-Gene Expression Profile (40-GEP) Test Identifies Patients with Node Negative Cutaneous Squamous Cell Carcinoma (cSCC) at Higher Risk of Metastasis Who May Benefit fromLocation: Room 4Presenter: – Castle Biosciences, Inc
Anesh Prasai, PhD – Castle Biosciences, Inc ### 2082801###Presenter######Castle Biosciences, Inc###Presenter: – Castle Biosciences, Inc
### 5:15 PM – 6:15 PM PT
3213 - Effect of External Beam Radiation Therapy (EBRT) and Brachytherapy (BT) on Circulating MDSC Populations in Patients Treated Definitively for Cervical CancerLocation: Hall B1Presenter: – University of Minnesota
Kelsey Wanhainen, PhD – University of Minnesota ### 1972823###Presenter######University of Minnesota###Presenter: – University of Minnesota
### - Wednesday, October 4, 2023
8:00 AM – 8:07 AM PT
264 - Efficacy and Toxicity of Different Target Volume Delineations of Radiotherapy Based on the Updated RTOG/NRG and EORTC Guidelines in Patients with High Grade Glioma: A Randomized, Controlled Clinical TLocation: Room 33Presenter: – Hunan Cancer Hospital
Feng Liu, MD – Hunan Cancer Hospital ### 1971964###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hunan Cancer Hospital###Presenter: – Hunan Cancer Hospital
### 8:10 AM – 8:17 AM PT
265 - Low Dose Fractionated Radiation Therapy as a Chemo-Potentiator of Salvage Temozolomide (TMZ) for Recurrent Anaplastic Astrocytoma (AA) and Glioblastoma Multiforme (GBM): A Single-Arm Phase I/II TrialLocation: Room 33Presenter: – Johns Hopkins University
Timothy Lin, MD, MBA – Johns Hopkins University ### 535807###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 8:20 AM – 8:27 AM PT
266 - Multi-Institutional Report of Re-Irradiation for Recurrent High-Grade GliomaLocation: Room 33Presenter: – Wake Forest Baptist Medical Center
Hosniya Zarabi, MD, MS, BS – Wake Forest Baptist Medical Center ### 1971965###Presenter######Wake Forest Baptist Medical Center###Presenter: – Wake Forest Baptist Medical Center
### 8:30 AM – 8:37 AM PT
267 - Oncogenic Activities of Tribbles1 (TRIB1) Pseudokinase Overexpressed in GBM Are Mediated By Protein-Protein InteractionsLocation: Room 33
Karnika Singh, PhD – OSU CCC ### 1971966###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###OSU CCC###Presenter: – OSU CCC
### 8:40 AM – 8:47 AM PT
268 - A Combined Phase 0/2 "Trigger" Trial of Niraparib in Combination with Radiation in Patients with Newly-Diagnosed GlioblastomaLocation: Room 33Presenter: – Barrow Neurological Institute
William Kennedy, MD – Barrow Neurological Institute ### 2082186###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Barrow Neurological Institute###Presenter: – Barrow Neurological Institute
### 8:50 AM – 9:00 AM PT
DiscussantLocation: Room 33Discussant: – Cleveland Clinic Taussig Cancer Center
Jennifer Yu, MD, PhD – Cleveland Clinic Taussig Cancer Center ### 524586###Discussant###Disclosures: Employment: Cleveland Clinic:Staff:Employee | Compensation: NIH: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Cleveland Clinic: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Case Comprehensive Cancer Center: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present | Ownership: Abbvie:Stock;Medtronics:Stock | Leadership: International Journal of Hyperthermia:Associate Editor;Molecular Carcinogenesis:Associate Editor;Frontiers in Oncology:Associate Editor###Cleveland Clinic Taussig Cancer Center###Discussant: – Cleveland Clinic Taussig Cancer Center
### 8:05 AM – 8:10 AM PT
1206 - Very Low Dose Radiation Therapy for Indolent Lymphomas: Comparing "Big Boom" (4Gy x 1) vs. "Boom Boom" (2Gy x 2)Location: Room 8Presenter: – Memorial Sloan Kettering Cancer Center
Brandon Imber, MD, MS – Memorial Sloan Kettering Cancer Center ### 536050###Presenter###Disclosures: Employment: Memorial Sloan Kettering Cancer Center:Assistant Attending Radiation Oncologist:Employee | Compensation: GT Medical Technologies: Education Meeting Faculty, Honoraria-End Date: November 2021 ;Telix Pharmaceuticals: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: November 2022 | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 8:10 AM – 8:15 AM PT
1208 - Distribution and Failure Patterns of Primary Central Nervous System Lymphoma Related to HippocampusLocation: Room 8Presenter: – Seoul National University
Hye-Jo Ryu, MD – Seoul National University ### 1972100###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University###Presenter: – Seoul National University
### 8:15 AM – 8:20 AM PT
1210 - Acute Pulmonary Toxicity after Allogeneic Stem Cell Transplantation Using Total Body Irradiation-Based Conditioning- Myeloablative vs. Non-Myeloablative RegimensLocation: Room 8Presenter: – Duke University Medical Center
Christopher Kelsey, MD, FASTRO – Duke University Medical Center ### 524559###Presenter###Disclosures: Employment: Duke University Medical Center:Professor:Employee | Compensation: Johnson and Johnson: Consultant, Compensation Payment-End Date: 12/7/2022 ;Proctor and Gamble: Consultant, Compensation Payment-End Date: 12/7/2022 | Ownership: none | Leadership: none###Duke University Medical Center###Presenter: – Duke University Medical Center
### 8:20 AM – 8:25 AM PT
1212 - Irradiated Extramedullary Acute Myeloid Leukemia Increases Survival in a Leukemic Mouse ModelLocation: Room 8Presenter: – University of Texas MD Anderson Cancer Center
Francisco Saenz, PhD, MS – University of Texas MD Anderson Cancer Center ### 1972101###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Texas MD Anderson Cancer Center###Presenter: – University of Texas MD Anderson Cancer Center
### 8:25 AM – 8:30 AM PT
1214 - First-in-Human Phase I Trial Combining Biologically Guided Radioimmunotherapy (RIT) Using a 90Y-Anti-CD25 Monoclonal Antibody (Mab) with CT-guided Total Marrow and Lymphoid Irradiation (TMLLocation: Room 8Presenter: – City of Hope National Medical Center
Jeffrey Wong, MD, FASTRO – City of Hope National Medical Center ### 535883###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 8:30 AM – 8:35 AM PT
1216 - Long-Term Toxicity after Total Body Irradiation-Based Conditioning Regimens for Allogeneic Stem Cell TransplantationLocation: Room 8Presenter: – Duke University School of Medicine
Pranalee Patel, MD, BS – Duke University School of Medicine ### 1972102###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University School of Medicine###Presenter: – Duke University School of Medicine
### 8:05 AM – 8:10 AM PT
1218 - Failure Mode and Effects Analysis for Treatment Workflow of a Novel Ring Gantry LinacLocation: Room 7Presenter: – University of Pittsburgh, Hillman Cancer Center
Shada Wadi-Ramahi, PhD – University of Pittsburgh, Hillman Cancer Center ### 1971539###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pittsburgh, Hillman Cancer Center###Presenter: – University of Pittsburgh, Hillman Cancer Center
### 8:10 AM – 8:15 AM PT
1220 - ACR Accreditation of a Novel Linac-Based kV-CBCT System on a High-Speed Ring-GantryLocation: Room 7Presenter: – New York Proton Center
Allison Haertter, MS – New York Proton Center ### 1972107###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###New York Proton Center###Presenter: – New York Proton Center
### 8:15 AM – 8:20 AM PT
1222 - Dosimetric Comparison of Adaptive Radiotherapy Modalities for Stereotactic Partial Breast IrradiationLocation: Room 7Presenter: – UT Southwestern Medical Center
Yesenia Gonzalez, PhD – UT Southwestern Medical Center ### 746616###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 8:20 AM – 8:25 AM PT
1224 - Extended Field Radiosurgery of Spinal Metastases with MRI-Guided Adaptive Planning: A Dosimetric StudyLocation: Room 7Presenter: – Sylvester Comprehensive Cancer Center
Beatriz Guevara, MS – Sylvester Comprehensive Cancer Center ### 1972108###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sylvester Comprehensive Cancer Center###Presenter: – Sylvester Comprehensive Cancer Center
### 8:25 AM – 8:30 AM PT
1226 - Predicting Prostate VMAT 3D Radiation Doses of Continuously Varying Organ Dose Trade-Offs Using a Conditional Variational AutoencoderLocation: Room 7Presenter: – Ohio State University James Cancer Hospital
Simeng Zhu, MD – Ohio State University James Cancer Hospital ### 1972109###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ohio State University James Cancer Hospital###Presenter: – Ohio State University James Cancer Hospital
### 8:30 AM – 8:35 AM PT
1228 - Brachytherapy Dose Prediction Based on Monte Carlo Simulations Using Artificial Neural NetworksLocation: Room 7Presenter: – Shanghai Sixth People's Hospital
Zhen Li, MS – Shanghai Sixth People's Hospital ### 1972110###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shanghai Sixth People's Hospital###Presenter: – Shanghai Sixth People's Hospital
### 9:15 AM – 9:45 AM PT
DiscussantLocation: Ballroom 20Discussant: – Dana-Farber Cancer Institute / Harvard Medical School
Kimmie Ng, MD, MPH – Dana-Farber Cancer Institute / Harvard Medical School ### 2087171###Discussant###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Dana-Farber Cancer Institute / Harvard Medical School###Discussant: – Dana-Farber Cancer Institute / Harvard Medical School
### 9:45 AM – 10:15 AM PT
DiscussantLocation: Ballroom 20Discussant: – MD Anderson Cancer Center
Kristy Brock, PhD, FASTRO – MD Anderson Cancer Center ### 524478###Discussant###Disclosures: Employment: The University of Texas MD Anderson Cancer Center:Professor:Employee | Compensation: RaySearch Laboratories: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: Present | Ownership: RaySearch Laboratories:Copyright | Leadership: none###MD Anderson Cancer Center###Discussant: – MD Anderson Cancer Center
### 10:30 AM – 10:37 AM PT
269 - More Efficient Auto-Segmentation Framework Using Patient-Specific Information for CBCT-Guided Adaptive RadiotherapyLocation: Room 5Presenter: – ASTRO Show Management
Yuxiang Liu, MS – ASTRO Show Management ### 1971991###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###ASTRO Show Management###Presenter: – ASTRO Show Management
### 10:40 AM – 10:47 AM PT
270 - New Data-Driven Gated (DDG) PET/CT for Radiation Treatment Planning of NSCLCLocation: Room 5Presenter: – MD Anderson Cancer Center
Tinsu Pan, PhD – MD Anderson Cancer Center ### 1971992###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 10:50 AM – 10:57 AM PT
271 - Failure Mode and Effects Analysis Prior to the Introduction of AI Generated GTVs for Brain Metastases in the Clinical WorkflowLocation: Room 5Presenter: – Memorial Sloan Kettering Cancer Center
Michalis Aristophanous, PhD – Memorial Sloan Kettering Cancer Center ### 1971993###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 11:00 AM – 11:07 AM PT
272 - An Automated Brain Metastasis Detection and Segmentation System from MRI with a Large Multi-Institutional DatasetLocation: Room 5Presenter: – Siemens Healthineers
Youngjin Yoo, PhD – Siemens Healthineers ### 1971994###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Siemens Healthineers###Presenter: – Siemens Healthineers
### 11:10 AM – 11:17 AM PT
273 - Clinical Outcomes of Image-Guided Volumetric Modulated Arc Therapy for Total Body IrradiationLocation: Room 5Presenter: – Arizona Oncology
Sarah Kilic, MD, MS – Arizona Oncology ### 1971995###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Arizona Oncology###Presenter: – Arizona Oncology
### 11:20 AM – 11:27 AM PT
274 - Dosimetric and Clinical Results of a Volumetric-Based Skin-Sparing Planning Technique for Patients Treated to the Breast and Chest Wall with Pencil Beam Scanning Proton TherapyLocation: Room 5Presenter: – Radiation Oncology Associates
Avani Rao, MD – Radiation Oncology Associates ### 524894###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Radiation Oncology Associates###Presenter: – Radiation Oncology Associates
### 10:30 AM – 10:37 AM PT
275 - Patient-Level Savings Using the Mark Cuban Cost Plus Drugs Company for Radiation Oncology PatientsLocation: Room 4Presenter: – MD Anderson Cancer Center
Ramez Kouzy, MD – MD Anderson Cancer Center ### 1972016###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 10:40 AM – 10:47 AM PT
276 - Clinical Sequalae of Initial Insurance Denials in a Large Academic Radiation Oncology CenterLocation: Room 4Presenter: – Memorial Sloan Kettering Cancer Center
Jacob Shin, MD – Memorial Sloan Kettering Cancer Center ### 537867###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 10:50 AM – 10:57 AM PT
277 - Association of Managed Medicaid Plans and Cancer Stage at DiagnosisLocation: Room 4Presenter: – Washington University School of Medicine
Justin Barnes, MD, MS – Washington University School of Medicine ### 595915###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University School of Medicine###Presenter: – Washington University School of Medicine
### 11:00 AM – 11:07 AM PT
278 - Comparing Changes in Medicare Reimbursement for Radiation Oncology and Medical Oncology (2010-2020)Location: Room 4Presenter: – Washington University in St. Louis School of Medicine
Jacob Hogan, BS – Washington University in St. Louis School of Medicine ### 1972017###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University in St. Louis School of Medicine###Presenter: – Washington University in St. Louis School of Medicine
### 11:10 AM – 11:17 AM PT
279 - Financial Improvements from Short Course Adjuvant Vaginal Cuff Brachytherapy (VCB) in Early Endometrial Cancer Compared to Standard of Care, "SAVE" TrialLocation: Room 4Presenter: – University of Utah Huntsman Cancer Institute
Cristina DeCesaris, MD – University of Utah Huntsman Cancer Institute ### 538445###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Utah Huntsman Cancer Institute###Presenter: – University of Utah Huntsman Cancer Institute
### 11:20 AM – 11:27 AM PT
280 - Unplanned Hospitalization and Subsequent Mortality in Lung Cancer Patients Undergoing Concomitant Chemo-/Immuno-Therapy and Radiotherapy: An Analysis of Over 10,000 Patients in a Nationwide DatabaseLocation: Room 4Presenter: – Rutgers Cancer Institute of New Jersey
Jongmyung Kim, MD, PhD – Rutgers Cancer Institute of New Jersey ### 1971978###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rutgers Cancer Institute of New Jersey###Presenter: – Rutgers Cancer Institute of New Jersey
### 10:35 AM – 10:40 AM PT
1230 - Hybrid Immuno-RT for Bulky Tumors: Standard Fractionation with Partial Tumor SBRTLocation: Room 8Presenter: – Huaxi Hospital
Ren Luo, MD, PhD – Huaxi Hospital ### 2088106###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Huaxi Hospital###Presenter: – Huaxi Hospital
### 10:40 AM – 10:45 AM PT
1232 - Fungal Depletion Bolsters Anti-Tumor Immune Response Elicited by Anti-PD1 Alone and in Combination with Radiation TherapyLocation: Room 8Presenter: – Cedars-Sinai Medical Center
Satchel Stevens, BS – Cedars-Sinai Medical Center ### 1972104###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 10:45 AM – 10:50 AM PT
1234 - Non-Canonical NF-kB Pathway Suppresses Anti-Tumor Micro-environment and Prompts Pre-Metastasis Niches for Conventional Fractionated RadiotherapyLocation: Room 8
Dawei Chen, MD, MB ### 2029570###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:50 AM – 10:55 AM PT
1236 - Irradiated Tumor Cells-derived Exosomes Modulate Macrophage Polarization by Targeting SHP-2 Mediated Metabolic ReprogrammingLocation: Room 8
Dawei Chen, MD, MB ### 2029570###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:55 AM – 11:00 AM PT
1238 - Radiation Therapy Sensitizes Head-and-Neck Cancer Cells to Killing by Chimeric Antigen Receptor (CAR)-NK Cells Targeting CD70Location: Room 8Presenter: – MD Anderson Cancer Center
Gohar Manzar, MD, PhD – MD Anderson Cancer Center ### 537790###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 11:00 AM – 11:05 AM PT
1240 - Malignant Peripheral Nerve Sheath Tumors Activate Distinct Immunosuppressive Pathways Following Radiotherapy and are Associated with Immune Depletion In VivoLocation: Room 8Presenter: – University of California, San Francisco
Iowis Zhu, PhD – University of California, San Francisco ### 1972106###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, San Francisco###Presenter: – University of California, San Francisco
### 10:35 AM – 10:40 AM PT
1242 - Evaluation of Pneumonitis in a Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilmumab or Nivolumab Alone following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB NonLocation: Room 7Presenter: – IU Health Methodist Hospital
Michael Weisman, MD – IU Health Methodist Hospital ### 1972111###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###IU Health Methodist Hospital###Presenter: – IU Health Methodist Hospital
### 10:40 AM – 10:45 AM PT
1244 - A Novel FDG PET and Mean Lung Dose Model to Identify Stage III NSCLC Patients at High Risk of Developing Early Radiation PneumonitisLocation: Room 7Presenter: – Memorial Sloan Kettering Cancer Center
Maria Thor, PhD, MS – Memorial Sloan Kettering Cancer Center ### 535996###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 10:45 AM – 10:50 AM PT
1246 - Association of Cardiac Dose with Cardiac Events and Survival for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Treated with Concurrent Chemoradiotherapy (cCRT) in the Era of Immune CheckpointLocation: Room 7Presenter: – University of Pennsylvania Health System
Nikhil Yegya-Raman, MD – University of Pennsylvania Health System ### 538407###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania Health System###Presenter: – University of Pennsylvania Health System
### 10:50 AM – 10:55 AM PT
1248 - Investigating Dosimetry and Imaging Biomarkers for Prediction of Major Adverse Cardiac Events Following Locally Advanced Non-Small Cell Lung Cancer RadiotherapyLocation: Room 7Presenter: – Stanford University
Hyunsoo No, MD, CMD – Stanford University ### 1972112###Presenter###Disclosures: Employment: Stanford University:Resident Physician, Radiation Oncology:Employee | Compensation: RSNA Research & Education Foundation: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 6/30/2024 ;TED Ed: Other, Honoraria-End Date: to present ;American College of Radiation Oncology: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 10/2023 | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 10:55 AM – 11:00 AM PT
1250 - Association of Left Ventricular Myocardium Dose Exposure with Heart Failure in Lung Cancer RadiotherapyLocation: Room 7Presenter: – Cedars-Sinai Medical Center
Katelyn Atkins, MD, PhD – Cedars-Sinai Medical Center ### 535835###Presenter###Disclosures: Employment: Cedars-Sinai Medical Center:Assistant Professor:Employee | Compensation: OncLive: Education Meeting Faculty, Honoraria-End Date: 04/2021 | Ownership: none | Leadership: none###Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 11:00 AM – 11:05 AM PT
1252 - Long-Term Toxicity in Patients Receiving Radiotherapy for Ultracentral Stage I Non-Small Cell Lung Cancer - A Secondary Analysis of the LUSTRE Randomized TrialLocation: Room 7Presenter: – BC Cancer Agency - Vancouver Island Centre
Che Hsuan David Wu, MD – BC Cancer Agency - Vancouver Island Centre ### 2073997###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###BC Cancer Agency - Vancouver Island Centre###Presenter: – BC Cancer Agency - Vancouver Island Centre
### 10:30 AM – 10:37 AM PT
281 - Health-Related Quality of Life at Five Years for a Randomized Trial of Tri-Modality Therapy with I-125 Brachytherapy, External Beam Radiation Therapy, and Short- vs. Long-Term Androgen Deprivation TheLocation: Room 1Presenter: – National Hospital Organization Tokyo Medical Center
Atsunori Yorozu, MD, PhD – National Hospital Organization Tokyo Medical Center ### 525290###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Hospital Organization Tokyo Medical Center###Presenter: – National Hospital Organization Tokyo Medical Center
### 10:40 AM – 10:47 AM PT
282 - Patient-Reported Urinary and Bowel Quality of Life Outcomes Following External Beam Radiotherapy with or without High-Dose-Rate Brachytherapy Boost: Post-Hoc Analyses of TROG 03.04 (RADAR)Location: Room 1Presenter: – Alfred Health Radiation Oncology
Wee Loon Ong, MBBS – Alfred Health Radiation Oncology ### 747114###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Alfred Health Radiation Oncology###Presenter: – Alfred Health Radiation Oncology
### 10:50 AM – 10:57 AM PT
283 - Conditional Risk and Predictive Factors Associated with Late Toxicity for Prostate Cancer Patients Treated with External Beam Radiotherapy Alone on Randomized Trial RTOG 0126Location: Room 1Presenter: – Thomas Jefferson University
Gregory Alexander, MD – Thomas Jefferson University ### 1972023###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 11:00 AM – 11:07 AM PT
284 - Late Urinary Toxicity and QOL with Curative Radiotherapy for High-Risk Prostate Cancer: Dose-Effect Relations in the POP-RT Randomized Phase III TrialLocation: Room 1Presenter: – The Christie NHS Foundation Trust
Priyamvada Maitre, MD – The Christie NHS Foundation Trust ### 1972024###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Christie NHS Foundation Trust###Presenter: – The Christie NHS Foundation Trust
### 11:10 AM – 11:17 AM PT
285 - Toxicity and Patient Reported Quality of Life after PSMA-PET and mpMRT-Based Focal Dose Escalated Definitive Radiotherapy in Prostate Cancer Patients: 2-Year Follow-Up of the HypoFocal Phase II TrialLocation: Room 1Presenter: – University Medical Center Freiburg
Simon Spohn, MD – University Medical Center Freiburg ### 1972025###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Medical Center Freiburg###Presenter: – University Medical Center Freiburg
### 11:20 AM – 11:27 AM PT
286 - Patient Reported Outcomes in High-Risk Prostate Cancer Patients with or without Testosterone Recovery after Androgen Deprivation TherapyLocation: Room 1
Abdenour Nabid, MD – CHUS ### 524757###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###CHUS###Presenter: – CHUS
### 11:30 AM – 11:40 AM PT
DiscussantLocation: Room 1Presenter: – University of Michigan
William Jackson, MD – University of Michigan ### 524732###Presenter###Disclosures: Employment: university of michigan:assistant professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 10:30 AM – 10:37 AM PT
287 - Treatment Terminations during Radiation Therapy: A Ten-Year ExperienceLocation: Room 2Presenter: – Northwell Health Center for Advanced Medicine
Jason Nosrati, MD – Northwell Health Center for Advanced Medicine ### 1972026###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwell Health Center for Advanced Medicine###Presenter: – Northwell Health Center for Advanced Medicine
### 10:40 AM – 10:47 AM PT
288 - Quantitative and qualitative impact of CT-Based Radiotherapy Dose Maps on Radiologists Interpretation of Post-treatment Thoracic Surveillance ImagingLocation: Room 2Presenter: – University of Washington School of Medicine
Kira Newell, BA – University of Washington School of Medicine ### 1972027###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington School of Medicine###Presenter: – University of Washington School of Medicine
### 10:50 AM – 10:57 AM PT
289 - Quality Assurance in a Phase III, Multicenter, Randomized Trial of POstmastectomy radioThErapy in Node posiTive Breast Cancer with or without Internal mAmmary nodaL Irradiation (POTENTIAL): A PlanningLocation: Room 2Presenter: – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Yuchun Song, MD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ### 1972028###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
### 11:00 AM – 11:07 AM PT
290 - Reducing Patient Care Delays in Radiation Oncology via Optimization of Insurance Pre-AuthorizationLocation: Room 2
Maxwell Tran, MD – MUSC ### 1972029###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MUSC###Presenter: – MUSC
### 11:10 AM – 11:17 AM PT
291 - Optimization of Workup Pathways to Decrease Radiotherapy Wait Times and Improving Patient Experience: A Single Center StudyLocation: Room 2
Abdulmajeed Dayyat, MD ### 1972030###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 11:20 AM – 11:27 AM PT
292 - Can We Improve the Quality of Care Delivered to Cervical Cancer Patients? Development of Quality Metrics and Quality Improvement Program at a Single InstitutionLocation: Room 2Presenter: – Cleveland Clinic Taussig Cancer Center
Sudha Amarnath, MD – Cleveland Clinic Taussig Cancer Center ### 524577###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 11:30 AM – 11:40 AM PT
DiscussantLocation: Room 2Discussant: – University of California, San Francisco
Manju Sharma, PhD – University of California, San Francisco ### 1972031###Discussant###Disclosures: Employment: UCSF:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of California, San Francisco###Discussant: – University of California, San Francisco
### 12:30 PM – 12:37 PM PT
293 - Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final Results of a Phase I TrialLocation: Room 1Presenter: – Institut Curie
Christophe Le Tourneau, MD, PhD – Institut Curie ### 537457###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Institut Curie###Presenter: – Institut Curie
### 12:40 PM – 12:47 PM PT
294 - Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Locally Advanced Laryngeal/Hypopharyngeal Carcinoma: Preliminary Results of INSIGHT StudyLocation: Room 1Presenter: – Fudan University Shanghai Cancer Center
Xiaomin Ou, MD – Fudan University Shanghai Cancer Center ### 525095###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fudan University Shanghai Cancer Center###Presenter: – Fudan University Shanghai Cancer Center
### 12:50 PM – 12:57 PM PT
295 - SBRT in 3 Fractions for T1 Glottic CancerLocation: Room 1Presenter: – Regina Elena National Cancer Institute
Giuseppe Sanguineti, MD, Mr – Regina Elena National Cancer Institute ### 524929###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Regina Elena National Cancer Institute###Presenter: – Regina Elena National Cancer Institute
### 1:00 PM – 1:07 PM PT
296 - Identifying a Dose Constraint for the Parotid Ducts: Impact on Patient Reported Xerostomia and Comparison to Conventional Parotid Gland Mean Dose SparingLocation: Room 1Presenter: – University of North Carolina
Shiva Das, PhD – University of North Carolina ### 746639###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of North Carolina###Presenter: – University of North Carolina
### 1:10 PM – 1:17 PM PT
297 - Dose Painting Radiotherapy Guided by Diffusion-Weighted Magnetic Resonance vs. 18F-FDG-PET/CT in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized, Controlled Clinical TrialLocation: Room 1Presenter: – Hunan Cancer Hospital
Feng Liu, MD – Hunan Cancer Hospital ### 1971964###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hunan Cancer Hospital###Presenter: – Hunan Cancer Hospital
### 1:20 PM – 1:30 PM PT
DiscussantLocation: Room 1Discussant: – University of Michigan
Michelle Mierzwa, MD – University of Michigan ### 746645###Discussant###Disclosures: Employment: University of Michigan:Associate Professor of Radiation Oncology:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: MROQC:Co-lead of Behavioral Health Committee###University of Michigan###Discussant: – University of Michigan
### 12:35 PM – 12:40 PM PT
1254 - Intracranial Control with Combined Dual Immune-Checkpoint Blockade and SRS for Melanoma and NSCLC Brain MetastasesLocation: Room 7Presenter: – Duke Cancer Institute
Eugene Vaios, MD, MBA – Duke Cancer Institute ### 1972114###Presenter###Disclosures: Employment: Duke Cancer Institute:Resident:Employee;Duke Cancer Institute:Fellow:Employee | Compensation: Glasshouse Health: Consultant, Compensation Payment-End Date: Present | Ownership: none | Leadership: none###Duke Cancer Institute###Presenter: – Duke Cancer Institute
### 12:40 PM – 12:45 PM PT
1256 - Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): One-Year Safety and Efficacy Outcomes From a Multicenter Phase I TrialLocation: Room 7Presenter: – University Hospitals Cleveland
Shearwood McClelland, MD – University Hospitals Cleveland ### 537469###Presenter###Disclosures: Employment: University Hospitals Seidman Cancer Center:Director of Spine Oncology:Employee | Compensation: Gilmartin Capital: Consultant, Compensation Payment-End Date: Ongoing ;GT Medical Technologies: Education Meeting Faculty, Travel Expenses-End Date: 2/26/23 | Ownership: none | Leadership: NRG Oncology:Rural Health Special Interest Group;National Medical Association:Research Committee;NRG Oncology:Scientific Core Committee###University Hospitals Cleveland###Presenter: – University Hospitals Cleveland
### 12:45 PM – 12:50 PM PT
1258 - Initial Report of Boswellia Serrata for Management of Cerebral Radiation Necrosis After Stereotactic Radiosurgery for Brain MetastasesLocation: Room 7Presenter: – Ohio State University
Rituraj Upadhyay, MD, MBBS, DNB – Ohio State University ### 746809###Presenter###Disclosures: Employment: The Ohio State University Wexner Medical Center:Resident physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Ohio State University###Presenter: – Ohio State University
### 12:50 PM – 12:55 PM PT
1260 - Frameless LINAC-Based Stereotactic Radiosurgery is Safe and Effective for Essential and Parkinsonian TremorLocation: Room 7Presenter: – University of Alabama Birmingham Hospital
Nii-Kwanchie Ankrah, MD – University of Alabama Birmingham Hospital ### 1972116###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Alabama Birmingham Hospital###Presenter: – University of Alabama Birmingham Hospital
### 12:55 PM – 1:00 PM PT
1264 - Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: A Toxicity AnalysisLocation: Room 7Presenter: – The Ohio State
Jennifer Matsui, PhD – The Ohio State ### 1972849###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Ohio State###Presenter: – The Ohio State
### 1:05 PM – 1:10 PM PT
2236 - Feasibility of Cognitive-Sparing Stereotactic Radiosurgery for Brain Metastases: Initial Report of Phase II COG-SRS TrialLocation: Room 7Presenter: – UCSD Radiation Medicine and Applied Sciences
Austin Hopper, MD – UCSD Radiation Medicine and Applied Sciences ### 747811###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSD Radiation Medicine and Applied Sciences###Presenter: – UCSD Radiation Medicine and Applied Sciences
### 12:35 PM – 12:40 PM PT
1266 - Very APBI in 1 or 2 Days: Late Toxicity and Early Oncological Outcomes of the GEC-ESTRO CohortLocation: Room 8
Jean-Michel Hannoun-Levi, MD, PhD ### 1973158###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:40 PM – 12:45 PM PT
1268 - Proton vs. Photons for Breast Cancer Patients with Immediate, Implant-Based Reconstruction Receiving Postmastectomy Radiotherapy: A Multicenter Pooled AnalysisLocation: Room 8Presenter: – Massachusets General Hospital
Myrsini Ioakeim-Ioannidou, MD – Massachusets General Hospital ### 575546###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Massachusets General Hospital###Presenter: – Massachusets General Hospital
### 12:45 PM – 12:50 PM PT
1270 - A Phase II Randomized Clinical Trial to Assess Toxicity and Quality of Life of Breast Cancer Patients with Hypofractionated vs. Conventional Fractionation Radiotherapy with Regional Nodal IrradiationLocation: Room 8Presenter: – Rede Mater Dei
Gabriel Gil, MD, PhD, MBA, MS – Rede Mater Dei ### 1973159###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rede Mater Dei###Presenter: – Rede Mater Dei
### 12:50 PM – 12:55 PM PT
1272 - Cardiological Safety of 5-Fraction Whole Breast IrradiationLocation: Room 8
Lorenzo Livi, MD ### 1973160###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:55 PM – 1:00 PM PT
1274 - Pattern and Complication of Reconstructed Breast Cancer Patients Who Received Postmastectomy Radiotherapy in the National Health Insurance Service CohortLocation: Room 8Presenter: – Seoul National University
Hye-Jo Ryu, MD – Seoul National University ### 1972100###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University###Presenter: – Seoul National University
### 1:00 PM – 1:05 PM PT
1276 - Identification and Dosimetric Analysis of Axillary Substructures Associated with Breast Cancer Related LymphedemaLocation: Room 8
Jia-Qi Huang ### 1973161###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 12:37 PM PT
305 - Risk of Sexual Dysfunction in Men Treated with Pelvic Radiation Therapy for Locally Advanced Rectal Cancer: 20 Years of Experience with 430 PatientsLocation: Room 4Presenter: – Memorial Sloan Kettering Cancer Center
Kush Patel, BA, MBS – Memorial Sloan Kettering Cancer Center ### 1972036###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 12:40 PM – 12:47 PM PT
306 - Prognostic Role and Time Varying Failure Hazard of Neoadjuvant Rectal (NAR) Scores in the Stellar Randomized Phase 3 TrialLocation: Room 4Presenter: – Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
Yuan Tang, MD – Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College ### 2087162###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College###Presenter: – Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
### 12:50 PM – 12:57 PM PT
307 - Relationships between Microbiome and Response to Neoadjuvant Chemoradiotherapy in Rectal CancerLocation: Room 4Presenter: – Seoul National University Hospital
Bum Sup Jang, MD, PhD – Seoul National University Hospital ### 535816###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University Hospital###Presenter: – Seoul National University Hospital
### 1:00 PM – 1:07 PM PT
308 - Long-Term Anorectal Function in Rectal Cancer Patients Managed by a Watch-and-Wait Strategy after Neoadjuvant Therapy: A Cross-Sectional StudyLocation: Room 4Presenter: – Fudan University Shanghai Cancer Center
Xin Jin, MD – Fudan University Shanghai Cancer Center ### 1972038###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fudan University Shanghai Cancer Center###Presenter: – Fudan University Shanghai Cancer Center
### 1:10 PM – 1:17 PM PT
309 - Phase 1 Trial of SPECT-Guided Liver-Directed Ablative Radiotherapy for Patients with Low Functional Liver VolumeLocation: Room 4Presenter: – MD Anderson Cancer Center
Enoch Chang, MD – MD Anderson Cancer Center ### 747716###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 1:20 PM – 1:27 PM PT
310 - Stereotactic Body Radiotherapy Combined with Sintilimab in Patients with Recurrent or Oligometastatic Hepatocellular Carcinoma: A Phase II Clinical TrialLocation: Room 4Presenter: – Zhongshan Hospital Fudan University
Shisuo Du, MD, PhD – Zhongshan Hospital Fudan University ### 2130575###Presenter######Zhongshan Hospital Fudan University###Presenter: – Zhongshan Hospital Fudan University
### 1:30 PM – 1:45 PM PT
DiscussantLocation: Room 4Discussant: – Stanford University
Erqi Pollom, MD, MS – Stanford University ### 746577###Discussant###Disclosures: Employment: Stanford:Associate Professor:Employee | Compensation: Vysioneer: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: ongoing | Ownership: none | Leadership: none###Stanford University###Discussant: – Stanford University
### 12:50 PM – 12:57 PM PT
307 - Relationships between Microbiome and Response to Neoadjuvant Chemoradiotherapy in Rectal CancerLocation: Room 4Presenter: – Seoul National University Hospital
Hye In Lee, MD – Seoul National University Hospital ### 1972037###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University Hospital###Presenter: – Seoul National University Hospital
### 1:30 PM – 1:40 PM PT
DiscussantLocation: Room 4Discussant: – Yale University School of Medicine
Kimberly Johung, MD, PhD – Yale University School of Medicine ### 524716###Discussant###Disclosures: Employment: Yale University School of Medicine: Associate Professor: Employee | Compensation: Role Topic Description-End Date: | Ownership: none | Leadership: none###Yale University School of Medicine###Discussant: – Yale University School of Medicine
### 12:30 PM – 12:37 PM PT
311 - Phase II Multi-Institutional Study of a Low-Dose (4Gy) Palliative Response-Adapted Radiotherapy Regimen for Symptomatic Bone Metastases from Multiple Myeloma: Planned Interim Analysis of First 40 PatiLocation: Room 5Presenter: – Cedars Sinai
Leslie Ballas, MD – Cedars Sinai ### 524742###Presenter###Disclosures: Employment: Cedars Sinai Medical Center:Physician:Employee | Compensation: Pfizer: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: 11/11/22 ;Blue Earth: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: 12/7/22 | Ownership: none | Leadership: none###Cedars Sinai###Presenter: – Cedars Sinai
### 12:40 PM – 12:47 PM PT
312 - Phase I Study of Bortezomib, Fludarabine, and Melphalan, with or without Total Marrow Irradiation As Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk or RLocation: Room 5Presenter: – City of Hope National Medical Center
Colton Ladbury, MD, BS – City of Hope National Medical Center ### 747995###Presenter###Disclosures: Employment: City of Hope National Medical Center:Resident Physician:Employee | Compensation: RefleXion Medical: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 12:50 PM – 12:57 PM PT
313 - Predictors of Local Control with Palliative Radiotherapy for Multiple MyelomaLocation: Room 5
Robert Gao, MD – Mayo Clinic ### 524858###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic###Presenter: – Mayo Clinic
### 1:00 PM – 1:07 PM PT
314 - Phase 2 Trial of Anti-PD1 and 8 Gy in 1 Fraction for Relapse/Refractory MyelomaLocation: Room 5Presenter: – Emory University
Mohammad Khan, MD, PhD – Emory University ### 1976471###Presenter###Disclosures: Employment: Emory University:Professor:Employee | Compensation: Merck Pharmaceuticals.: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Salary Support-End Date: 2025 ;Varian: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 2022 | Ownership: none | Leadership: none###Emory University###Presenter: – Emory University
### 1:10 PM – 1:17 PM PT
315 - Radiation in a New Era of Multiple Myeloma Management: Patterns of Utilization, Clinical, Radiologic, and Biochemical Outcomes, and Possible Genomic Correlates of ResponseLocation: Room 5Presenter: – Memorial Sloan Kettering Cancer Center
Alexandra Dreyfuss, MD – Memorial Sloan Kettering Cancer Center ### 1972363###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 1:20 PM – 1:27 PM PT
316 - Clinical Outcome and Patterns of Failure in Patients with Solitary Plasmacytoma Treated with Radical RadiotherapyLocation: Room 5Presenter: – All India Institute of Medical Sciences
Ahitagni Biswas, MD, DNB, FRCR – All India Institute of Medical Sciences ### 535874###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###All India Institute of Medical Sciences###Presenter: – All India Institute of Medical Sciences
### 1:30 PM – 1:40 PM PT
DiscussantLocation: Room 5Discussant: – Institut Curie
Youlia Kirova, MD – Institut Curie ### 593453###Discussant###Disclosures: Employment: Institut Curie:Associate Professor Medical Doctor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Institut Curie###Discussant: – Institut Curie
### 12:30 PM – 12:37 PM PT
298 - Landscape of the Radiosensitizing Properties of Targeted Agents from the NCI CTEP Portfolio across Genomically Diverse 3D Tumor ModelsLocation: Room 2Presenter: – Massachusetts General Hospital
Henning Willers, MD, FASTRO – Massachusetts General Hospital ### 535660###Presenter###Disclosures: Employment: Massachusetts General Hospital:Associate Radiation Oncologist:Employee;Massachusetts General Hospital:Assistant gynecologist:Employee;Harvard School of Public Health:Investigator:Employee | Compensation: NIH/NCI: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: present ;Department of Defense: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: present ;Apple Inc: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: present | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 12:40 PM – 12:47 PM PT
299 - Intercellular Mechanisms of Therapeutic Resistance at the Tumor-Stromal Interface Using Ultra High-Plex Single-Cell Spatial Transcriptomics and Genetically-Engineered TumoroidsLocation: Room 2
Ryan Zhao, MD ### 2158963###Presenter#########Presenter:
### 12:50 PM – 12:57 PM PT
300 - Coupling In Vivo CRISPR Perturbation with Single Cell Transcriptomics Defines Gene-Treatment Interactions and Reveals the Role of DNA-PK as a Targetable Radiation Vulnerability in GlioblastomLocation: Room 2
S. John Liu, MD, PhD – UCSF ### 747161###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSF###Presenter: – UCSF
### 1:00 PM – 1:07 PM PT
301 - Genetically Engineered Mouse Models of CIC-DUX4 Sarcoma Reveal an Unexpected Sensitivity to Histone Deacetylase (HDAC) InhibitionLocation: Room 2Presenter: – Duke University School of Medicine
Peter Hendrickson, MD, PhD – Duke University School of Medicine ### 1976472###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University School of Medicine###Presenter: – Duke University School of Medicine
### 1:10 PM – 1:17 PM PT
302 - Enhancing Immune-Mediated Radiotherapy Efficacy in Murine Models of Head and Neck Cancer through Peroxisome Proliferator-Activated Receptor ModulationLocation: Room 2Presenter: – University of Colorado Anschutz Medical Campus
Richard Ross, MD – University of Colorado Anschutz Medical Campus ### 525097###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Colorado Anschutz Medical Campus###Presenter: – University of Colorado Anschutz Medical Campus
### 1:20 PM – 1:27 PM PT
303 - Gamma Secretase Inhibition Sensitizes Pancreatic Adenocarcinoma Tumors to RT In VivoLocation: Room 2Presenter: – Thomas Jefferson University
Adam Mueller, MD, PhD – Thomas Jefferson University ### 746774###Presenter###Disclosures: Employment: Thomas Jefferson University:Assistant Professor:Employee | Compensation: Cosmocyte: Consultant, Uncompensated-End Date: to present ;ViewRay Corporation: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Salary Support-End Date: Present | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 1:30 PM – 1:37 PM PT
304 - Listeriolysin O Drives Innate and Adaptive Immune Responses to CD47 ImmunotherapyLocation: Room 2Presenter: – MD Anderson Cancer Center
Benjamin Schrank, MD, PhD – MD Anderson Cancer Center ### 1972198###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### - Sunday, September 29, 2024
8:00 AM – 8:10 AM PT
Quick Pitch Session - Abstract Presenter Reg TestPresenter: – TEST Company
MIT TEST, BS – TEST Company ### 2311805###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###TEST Company###Presenter: – TEST Company
### 8:00 AM – 8:10 AM PT
Scientific Session - Abstract Presenter Reg TestPresenter: – Test Company 3
Resident Fellow Test, DO – Test Company 3 ### 2311806###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Test Company 3###Presenter: – Test Company 3
### 9:30 AM – 9:40 AM PT
Clinical Trials Session - Abstract Presenter Test AbstractPresenter: – TEST Company
Bandana TEST, MD – TEST Company ### 2311794###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###TEST Company###Presenter: – TEST Company
### - Monday, September 30, 2024
1:30 PM – 1:40 PM PT
Plenary Session - Abstract Presenter Reg TestPresenter: – TEST Company 2
Medical Director TEST, BS – TEST Company 2 ### 2311795###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###TEST Company 2###Presenter: – TEST Company 2
### - Wednesday, October 2, 2024
6:00 AM – 7:00 AM PT
TEST 022324Presenter: – American Society for Radiation Oncology
Onon Ichinkhorloo, MSM – American Society for Radiation Oncology ### 1956987###Presenter###Disclosures: Employment: ASTRO:Sr. Education Program Coordinator:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###American Society for Radiation Oncology###Presenter: – American Society for Radiation Oncology
### 6:00 AM – 7:00 AM PT
TEST 022324Presenter: – TEST International Company
International TEST, PhD – TEST International Company ### 2311788###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###TEST International Company###Presenter: – TEST International Company
###